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ABSTRACT 
Light-Triggered Release of DNA from Plasmon-Resonant Nanoparticles  
by 
Ryan Huschka 
Plasmon-resonant nanoparticle complexes show promising potential for light-
triggered, controllable delivery of deoxyribonucleic acids (DNA) for research and therapeutic 
purposes.  For example, the approach of RNA interference (RNAi) ‒ using antisense DNA or 
RNA oligonucleotides to silence activity of a specific pathogenic gene transcript and reduce 
expression of the encoded protein ‒ is very useful in dissecting genetic function and holds 
promise as a molecular therapeutic.  Herein, we investigate the mechanism and probe the in 
vitro therapeutic potential of DNA light-triggered release from plasmonic nanoparticles.   
First, we investigate the mechanism of light-triggered release by dehybridizing 
double-stranded (dsDNA) via laser illumination from two types of nanoparticle substrates: 
gold (Au) nanoshells and Au nanorods. Both light-triggered and thermally induced releases 
are distinctly observable from nanoshell-based complexes.  Surprisingly, no analogous 
measurable light-triggered release was observable from nanorod-based complexes below the 
DNA melting temperature. These results suggest that a nonthermal mechanism may play a 
role in light-triggered DNA release. 
Second, we demonstrate the in vitro light-triggered release of molecules non-
covalently attached within dsDNA bound to the Au nanoshell surface.  DAPI (4',6-
diamidino-2-phenylindole), a bright blue fluorescent molecule that binds reversibly to 
double-stranded DNA, was chosen to visualize this intracellular light-induced release 
process.  Illumination through the cell membrane of the nanoshell-dsDNA-DAPI complexes 
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dehybridizes the DNA and releases the DAPI molecules within living cells.  The DAPI 
molecules diffuse to the nucleus and associate with the cell’s endogenous DNA.  This work 
could have future applications towards drug delivery of molecules that associate with 
dsDNA.   
Finally, we demonstrate an engineered Au nanoshell (AuNS)-based therapeutic 
oligonucleotide delivery vehicle, designed to release its cargo on demand upon illumination 
with a near-infrared (NIR) laser. A poly(L)lysine peptide (PLL) epilayer coated onto  the 
AuNS surface (AuNS-PLL) is used to capture intact, single-stranded antisense DNA 
oligonucleotide, or alternatively, double-stranded short-interfering RNA (siRNA) molecules. 
A green fluorescent protein (GFP)-expressing human lung cancer H1299 cell line was used 
to determine cellular uptake and GFP gene silencing mediated by AuNS-PLL delivery 
vector.  The light-triggered release of oligonucleotides could have broad applications in the 
study of cellular processes and in the development of intracellular targeted therapies.  
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Chapter 1 
 
Introduction 
Due to the unique optical properties of metallic nanoparticles, their use is becoming 
widespread in a variety of fields such as chemical and biological sensing,
1-4
 localized surface 
plasmon resonance (LSPR) sensing
5-6
, biomedical imaging
7-13
, photothermal cancer therapy
7-
8, 14-16
, and solar energy collection.
17-19
  Nanoparticles made of Au are particularly interesting 
for biomedical applications because Au is bioinert.
20
  The Au surface can be easily 
functionalized typically via Au-thiol chemistry with therapeutics, MRI contrast agents, 
fluorescent markers, and targeting moieties.  In this way, a nanoparticle can be designed to be 
a theranostic tool which is used to both diagnose and treat a particular disease.  Upon 
excitation with light, Au nanoparticles support a plasmon resonance, a collective excitation 
of the conduction band electrons, which can be advantageously utilized for additional 
functionality.  For example, the quantum yield of a fluorophore attached in the near vicinity 
of the nanoparticle is enhanced due to the plasmonic properties, which results in brighter 
fluorescence images and improved diagnostics.
10
   
In this thesis, the plasmonic properties of silica-Au nanoshells, a spherical silica core 
surrounded by a thin layer of Au, are utilized to accomplish light-triggered release of 
molecules and deoxyribonucleic acids (DNA) noncovalently attached to the Au surface.  The 
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advantage of this release strategy is spatial and temporal control over delivery of therapeutics 
for diseases such as cancer.  The American Cancer Society predicts that one in two men and 
one in three women will be diagnosed with cancer in their lifetimes.
21
  In addition to 
advances in traditional therapies such as surgery, radiation therapy, and chemotherapy, new 
therapy strategies need to be developed.  Gene therapy shows great promise as a 
nontraditional therapy for cancer and other genetic diseases.
22-24
  While traditional cancer 
therapies work by inducing cell death either by necrosis or apoptosis, gene therapy works by 
altering the cellular genome in order to modify or control the expression of proteins that are 
malfunctioning and causing cancer to grow.  In this way gene therapy 'fixes' a mutated cell 
rather than destroying it.
25
  The delivery of gene therapeutics is an extremely challenging 
problem and has been the focus of immense research.
26-34
  Herein, the use of silica-Au 
nanoshells as a potential gene therapy delivery vector with light-triggered release 
functionality is investigated.  
1.1. Scope of this thesis 
Chapter 2 will give some general background on gene therapy as well as a description 
of both the nanoparticles and techniques used in this thesis.  In Chapter 3, the observation of 
dehybridizing dsDNA bound to an Au nanoshell, in response to continuous wave (CW) laser 
excitation is reported.  In Chapter 4, the mechanism of this dsDNA dehybridization is 
investigated by comparing the light-triggered dehybridization release behavior when dsDNA 
is attached to either nanoshells or nanorods.  In Chapter 5, DAPI molecules, a common 
fluorescence small molecule used to stain the nucleus in fluorescence microscopy, non-
covalently associate with the dsDNA attached to the Au nanoshell surface.  After incubation 
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in an in vitro cancer cell line, the laser irradiation releases the DAPI molecules, which then 
diffuse to the genomic DNA and stain the cell nucleus.  In Chapter 6, light-triggered release 
of gene therapeutics from Au nanoshells is performed to controllably deliver in vitro 
antisense ssDNA oligonucleotides and short-interfering RNA (siRNA) in order to regulate 
the biosynthesis of a target green fluorescent protein.  Chapter 7 gives general conclusions 
from this thesis and provides future impact of this research.   
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Chapter 2 
 
Background 
2.1. Au Nanoshell Synthesis and Characterization 
 The nanoparticle predominately used within this thesis is the Au nanoshell, which 
consists of a spherical silicon dioxide (SiO2) core surrounded by a thin layer of Au.  The 
plasmon resonance of the nanoshell can be tuned from the visible to the infrared regions of 
the electromagnetic spectrum by changing the size of the core with respect to the thickness of 
the shell, Figure 2-1.
35
  A thinner Au shell red-shifts the resonance and a thicker Au shell 
blue-shifts the resonance. Additionally, the plasmon resonance is dependent upon the 
dielectric of the core, shell and embedding medium.
36-38
  This tunability is particularly 
advantageous for biomedical applications because the resonance can be tuned into the near-
infrared (NIR) “water window” (~700-900 nm), where human tissue is maximally 
transparent allowing light to penetrate several inches.
39
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Figure 2-1.  Theoretically calculated optical resonances of metal nanoshells with a 60nm 
radius silica core and varying Au shell thicknesses (20 nm, 10 nm, 7 nm, and 5 nm).  
Figure adapted from Ref. 
35
  
 
 The SiO2-Au nanoshell is fabricated following previously reported protocols.
40-41
 
First, monodisperse spherical silica nanoparticles are fabricated via the Stöber method, 
Figure 2-2A, which consist of a condensation reaction of tetraethyl orthosilicate (TEOS) at 
room temperature under alkaline conditions in an ethanol:water mixture.  The silica cores are 
then functionalized with 3-aminopropyltriethoxysilane (APTES), Figure 2-2B.  The triethoxy 
silane functional group of the APTES molecule attaches to the silica core, which leaves the 
primary amine functional facing outward.  In a separate reaction, small Au nanoparticles ~2-
3 nm in diameter are synthesized using tetrakis(hydroxymethyl)phosphonium chloride 
(THPC) as the reducing agent from the method reported by Duff, et al.
42
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Figure 2-2.  Schematic of nanoshell synthesis.  (A) Silica core, (B)silica core 
functionalized with APTES, (C) 2-3 nm THPC Au “islands” attached, and (D) Au shell 
after electroless plating.   
These 2-3 nm Au nanoparticles are then attached through the primary amine groups 
on the APTES-functionalized silica nanoparticles and serve as nucleation sites for future 
deposition and growth of the gold shell, Figure 2-2C.  These silica cores decorated with 
THPC Au nanoparticles are added in the correct volume ratio to a potassium carbonate 
growth solution containing Au (III) chloride.  A weak reducing agent (formaldehyde or 
carbon monoxide) is added, which reduces the Au (III) ions onto the Au islands, which then 
coalesce into a complete Au shell, Figure 2-2D.  Starting with new reagents, Au nanoshells 
can be fabricated in approximately 4 weeks; however, if aged solutions are already prepared, 
nanoshells can be made in 2-4 days.  For a detailed protocol, see appendix B.  
The size of a nanoshell is denoted by the radius of the silica core (r
1
) and the radius of 
the nanoshell (r
2
), inset of Figure 2-3a.  Figure 2-3 is characterization data for [r
1
, r
2
] = [59, 
72] nm nanoshells, which consists of an UV-Vis-NIR spectrum (Figure 2-3a) and a scanning 
electron microscopy (SEM) image (Figure 2-3b).   
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Figure 2-3. Characterization of silica-Au nanoshells. (a) Optical extinction spectra of 
[r
1
, r
2
] = [59, 72] nm nanoshells (λmax ≈ 800 nm). (b) SEM image of nanoshells 
corresponding to spectrum shown in (a). 
2.2. Plasmon Hybridization 
Plasmon hybridization is a very helpful intuitive model for describing the coupling 
observed in complex plasmonic systems.  It is the electromagnetic analog of molecular 
orbital theory which is used to predict the interaction of atomic orbitals for the formation of 
molecular orbitals.  For a silica core
_
Au shell nanoshell, plasmon hybridization explains the 
observed shifts in the plasmon resonance due to changes in the Au shell thickness, Figure 
2-4.  The model for a nanoshell is based upon the coupling of a spherical Au particle plasmon 
with an inner spherical cavity plasmon.  The outside of the nanoshell acts as the spherical Au 
particle plasmon and the inside of the nanoshell acts at the inner spherical cavity plasmon.  
The coupling results in a lower energy symmetric mode and a higher energy antisymmetric 
mode.  The symmetric mode is dipole active and can be excited by light; therefore it is often 
referred to as a bright mode.  The antisymmetric mode is not dipole active and cannot be 
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excited by light; therefore it is often referred to as a dark mode.  As the shell become thinner, 
the coupling between the outer spherical plasmon and the inner cavity plasmon become 
stronger which results in a larger energy splitting between the symmetric and antisymmetric 
modes.  For the optically excited bright mode, this corresponds to a lowering in energy and a 
redshift in the UV/Vis extinction spectrum.   
 
 
Figure 2-4.  Intuitive plasmon hybridization model for a silica core, Au shell nanoshell.  
The coupling of a sphere plasmon and a cavity plasmon results in a lower energy 
symmetric mode (ω-) and a higher energy antisymmetric mode (ω+).  Figure adapted 
from Ref. 
43
  
2.3. Au Nanorods Fabrication and Characterization 
Au nanorods are another type of Au nanoparticle described in this thesis, and were 
synthesized using a previously published CTAB seed-mediated growth method.
44
  Au 
9 
 
 
 
nanorods consist of strictly Au synthesized in an elongated rod-like structure.  Nanorods have 
two primary plasmonic modes, whose excitation is sensitive to the polarization of incident 
light: the transverse mode, where the collective electronic oscillation of the plasmon occurs 
perpendicular to the long axis of the nanoparticle, and the longitudinal mode, where the 
plasmon oscillation occurs parallel to the long axis of the nanoparticle.  While the resonance 
wavelength of the Au nanorod transverse plasmon is similar to that for Au colloid (~520 nm), 
the longitudinal resonance wavelength redshifts with increasing aspect ratio (AR),
45
 which is 
defined as the nanorod length (l) divided by the nanorod width(w), AR= l/w, inset of Figure 
2-5b. 
 
Figure 2-5. Characterization of Au nanorods.  (a) Transmission electron microscope 
(TEM) image of [w, l] = [13, 47] nm) (B) Extinction spectra of solution of nanorods with 
(λmax ≈ 788 nm).  Inset is schematic of nanorod. 
 
The synthesis of Au nanorods consists of first making a seed solution of Au colloid 
stabilized by a bilayer of CTAB surfactant.  To make the seed solution, Au (III) chloride 
(HAuCl4) is mixed with a CTAB solution. Sodium borohydride (NaBH4), a fast reducing 
agent, is quickly added which reduces the Au (III) ions into Au colloid.  A CTAB bilayer 
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acts as a stabilizing layer around the Au colloid.  Next, these seed particles are added to a 
growth solution consisting of HAuCl4, silver (I) nitrate (AgNO3), and Ascorbic acid, a slow 
reducing agent, dissolved in a CTAB solution.  Once, the seed solution is added to the 
growth solution, the nanorods are placed in a 27°C water bath for 2 hours.  The CTAB binds 
more strongly to the {110} facet compared to the {100} facet of Au.  Therefore, the Au ions 
in the growth solution are preferentially reduced onto the {100} facet,
46
 producing the rod-
like shape.  The reaction was stopped and the nanorods were concentrated by centrifugation 
and resuspended in Milli-Q water.  If kept in the refrigerator, they were stable for months.  
For a detailed protocol of nanorod synthesis, refer to section 4.2.   
Figure 2-5 shows the characterization data for [w, l] = [13, 47] nm nanorods, which 
consists of a transmission electron microscopy (TEM) image (Figure 2-5a) and an UV-Vis-
NIR spectrum (Figure 2-5b). 
2.4. Fluorescein-tagged DNA 
Throughout this thesis, a common method to investigate light-triggered release of 
DNA from Au nanoparticles is to use fluorescently-tagged DNA oligonucleotides.  
Fluorescence is chosen because of its high sensitivity and is used to correlate fluorescence 
intensity with DNA concentration.  Fluorescein is predominately used because fluorescein 
has a high quantum yield and does not absorb near the NIR 800nm laser, which reduces the 
rate of photobleaching.  DNA oligonucleotides coupled with fluorescein are purchased from 
Integrated DNA technologies.  The DNA concentration is determined by the absorption peak 
at 260 nm and the calculated extinction coefficient for the DNA oligonucleotide.  For each 
known concentration, the fluorescence emission curve is measured using a fluorescence 
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spectrophotometer (Excitation λ: 495 nm, Emission Spectrum: 500-540 nm). Because the 
fluorescein emission peak wavelength is at 520 nm, a standard curve of fluorescence 
intensity at 520 nm versus DNA concentration was made, Figure 2-6A. 
 
Figure 2-6.  (A) Standard curve of DNA concentration (nM) versus fluorescence 
intensity at 520nm.  (B) Emission spectra (Ex λ: 495nm) of fluorescein-tagged DNA 
before (black) and after (red) 800 nm laser irradiation at 1 W/cm2 for 5 minutes. 
 
The fluorescence properties of fluorescein are pH dependent, so the fluorescein-
tagged DNA is suspended in Tris-EDTA (TE) buffer (pH = 7.5) for all fluorescence 
measurements.  Additionally, to reduce fluorescein photobleaching overtime solutions are 
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kept in the dark.  In order to ensure that laser irradiation does not affect the fluorescence 
properties of fluorescein, the fluorescence intensity was checked before and after laser 
irradiation, which showed the fluorescence properties were unchanged, Figure 2-6B. 
2.5. Flow cytometry 
In this thesis, flow cytometry is used in Chapter 5 to measure the fluorescence of 
nuclei and in Chapter 6, when fluorescence activated cell sorting is used to separate living 
from necrotic  cells. Flow cytometry is a common biological analysis technique used for a 
variety of applications including cell cycle analysis and viability, fluorescence activated cell 
sorting, DNA and RNA content, cell counting and cell complexity, as well as others.
47-48
  
Flow cytometry does multiparametric analysis of the physical and chemical makeup of each 
individual cell and can analyze thousands of cells per second.  It works by the following 
process, Figure 2-7. 
   
Figure 2-7. Schematic of a flow cytometry instrument. 
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First the cells are suspended in a stream of fluid and hydrodynamically focused into a 
“single-file” line in order to probe one cell at a time. A light source, either white light or a 
laser, is focused onto this thin stream of sheath fluid.  As the cell passes through the light 
source it scatters light, which is picked up by forward-scattering and side-scattering 
detectors.  The forward scattering detector gives information about the cell volume.  The 
side-scattering detector gives information about cell complexity, such as the shape of the 
nucleus, cytoplasmic granules or membrane roughness.  If the cell contains fluorescence 
signatures or fluorescence markers, then fluorescence detectors pick up these signals.  
Thousands of cells are analyzed within a short sampling time and the data is often plotted as 
a histogram for one parameter measurements or as a dot plot for two parameter 
measurements.   
2.6. Gene therapy 
The fundamental definition of gene therapy is to insert or alter genes—the DNA 
sequences containing all information needed to express specific proteins—in cells, resulting 
in therapeutic benefits for specific diseases. The goal is to control and modify the expression 
of certain specific proteins associated with the cause or occurrence of a disease. When a 
protein is undesirably expressed by unhealthy cells, inhibiting its functionality or arresting its 
expression is a process known as downregulation: conversely, enabling protein expression is 
referred to as upregulation. Following the completion of the sequencing of the human 
genome, gene therapy is the next logical step in the development of advanced medical 
treatments for human disease. 
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Recently, several approaches to gene delivery involving nucleic acids (DNA or RNA) 
have emerged as potential oligonucleotide-based therapeutic strategies for various diseases. 
There are four major classes of oligonucleotide therapy
25
: (i) Plasmid therapy, (ii) Antigene 
therapy, (iii) Antisense oligonucleotide and short interfering RNA (siRNA) therapy, and (iv) 
Aptamer therapy (Figure 2-8). Plasmid therapy targets DNA and introduces new genes that 
express proteins missing in cells. Plasmids are long, double-stranded DNA containing the 
foreign genetic code, delivered inside cells, to diffuse into the nucleus and become 
incorporated into the cell’s genetic material.49 Once integrated with the cell’s DNA, plasmids 
become part of the genetic material, allowing continuous expression of a specific missing 
protein. Antigene therapy directly targets and binds to specific segments of DNA, preventing 
transcription to the mRNA and thus preventing protein expression. Antisense and siRNA 
therapies target messenger RNA (mRNA), the intermediary between DNA and functional 
protein, and can selectively inhibit the expression of a specific protein. Antisense is based on 
hybridizing a short ssDNA sequence (15–30 bases) to its complementary region on the 
mRNA; once bound, it blocks further translation of the specific mRNA, arresting protein 
synthesis.
50
 siRNA is a double-stranded RNA sequence, nominally 20 base pairs long, 
containing the complement of the target mRNA. siRNA therapy involves a more complicated 
mechanism, wherein a combination of molecular complexes destroy the target mRNA and 
result in gene silencing.
51
. Aptamers are short single or double-stranded DNA that have been 
combinatorially selected to recognize and bind to specific target proteins, post-
translationally, inhibiting their functionality for therapeutic benefit.
52
 Here we focus on 
antisense oligonucleotide delivery. 
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Figure 2-8.Schematic of the four major types of DNA-based therapies. Plasmid DNA 
enters the nucleus and biosynthesize new healthy protein. Antigene oligonucleotides 
enter the nucleus, form a triplex with the genomic DNA, and block transcription. 
Antisense oligonucleotides bind to mRNA, located in the cytoplasm, and block 
translation. Aptamers act as a conventional type of drug by targeting the 
malfunctioning protein directly. 
 
2.7. Challenges of Antisense Oligonucleotide and siRNA Gene Therapy. 
Antisense therapy was first suggested by Stephenson and Zamecnik 30 years ago.
53
 
The principle of antisense therapy is very simple: design a short single-stranded 
oligonucleotide to hybridize to a particular messenger RNA (mRNA) target, which then 
inhibits the translation of that specific mRNA sequence into its corresponding protein. 
Antisense therapy has been suggested as a therapeutic strategy for cancer, viral infections and 
inflammatory diseases.
28
 However, there are several major inherent challenges to antisense 
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delivery that have impeded its translation into clinical practice.
54
 Oligonucleotides by 
themselves cannot be injected directly into the bloodstream for systemic delivery, due to their 
rapid degradation (<20 min) by serum nucleases. A carrier that protects the oligonucleotides 
from enzymatic degradation is therefore essential to any practical delivery strategy. The 
DNA carrier must also be small enough and possess favorable chemical properties to 
extravasate (be removed from the bloodstream), be taken up by cells, deliver the 
oligonucleotide cargo into the cells of interest, and access the cell’s genetic material so that it 
is available to perform its therapeutic mission. Intracellular uptake of foreign materials or 
structures, a process known as endocytosis, typically results in sequestration of the foreign 
object within an endosomal compartment inside the cell. Here again, the oligonucleotide may 
be subject to enzymatic degradation within the endosome. For the oligonucleotide to have its 
intended therapeutic effect, it must be released, or diffused from, the endosomal 
compartment into the cytosol and within an effective distance of the cell nucleus or 
ribosome, depending on its specific gene target. Originally, viruses were proposed as 
delivery vectors for gene therapy, because their own replication requires the injection of their 
genetic material into cellular hosts. Despite their inherent effectiveness in delivering 
oligonucleotides in vivo, viral vectors have induced unexpected and highly deleterious 
immune system responses in clinical subjects resulting in death, which is likely to prevent 
their ultimate approval for clinical use.
55
 
To realize the promise of gene therapy as a new tool in advanced clinical medicine, 
safe and effective non-viral delivery vectors are critically needed.
56-57
 An ideal non-viral 
gene therapy vector would have several important properties. It would (1) induce no 
immunogenic response,
26, 29, 58
 (2)maintain high stability against nucleases in the circulatory 
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system,
27, 59
 (3) target, and endocytosis into, specific cells of interest,
60
 and (4) provide a 
means for the efficient release of oligonucleotide cargo from the endosomal compartment. 
These requirements have led to a strong and growing interest in Au nanoparticles of various 
shapes and sizes as non-viral vectors for gene therapy. The biocompatibility of Au 
nanoparticles and nanostructures is well established. Oligonucleotides can be bound to the 
surface of a Au nanoparticle in relatively dense monolayers, greatly increasing their stability 
against degradation by nucleases. The facile binding of various types of biomolecules to the 
surfaces of Au nanoparticles enables multiple functions to be imparted on the same 
nanoparticle ‘platform’: for example, combining oligonucleotide loading with antibody 
conjugation for targeting specific cells or tissues is realizable with this approach. Finally, 
remote-controlled release of DNA from a nanoparticle complex is made possible by the 
resonant optical properties of Au nanoparticles and nanostructures (Figure 2-3).
61-64
  Resonant 
light absorption provides both spatial and temporal control for oligonucleotide release, which 
could be highly useful in research as well as in treatment scenarios. In addition, the energy 
input due to resonant light absorption and the accompanying local photothermal heating 
response may also assist diffusion of the oligonucleotides out of the endosomal compartment. 
In particular, nanoparticle-based complexes that respond to near infrared light, at 
wavelengths not significantly absorbed by cellular material, and release DNA upon resonant 
illumination would provide an ideal platform for light-controlled gene therapy. 
2.8. Au nanoparticles and their photophysical properties 
The combination of Au nanoparticles and biomolecules has enabled considerable 
advances in diagnostic and therapeutic nanomedicine.
65
 In addition to biocompatibility and 
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ease of fabrication and functionalization, the optical properties of certain noble metal 
nanoparticles are ideal for biomedical applications. The interaction of light with noble metal 
nanoparticles results in collective oscillations of the free electrons in the metal known as 
localized surface plasmons. On resonance, a metallic nanoparticle interacts strongly with 
incident light, possessing an extinction cross section nominally five times its physical cross 
section. Resonant illumination can result in strong light scattering (useful in biological 
sensing and imaging) and strong absorption, with relative magnitudes depending upon 
absolute nanoparticle size. As absorbers, plasmon-resonant nanoparticles are unparalleled 
light-to-heat converters, dissipating energy via their lattice phonons.
66
 
Due to their extraordinarily large absorption cross sections and their inability to re-
emit light, the photothermal properties of metallic nanoparticles are arguably their dominant 
physical characteristic.
67-69
 The physical process underlying the photothermal response of 
metal-based nanoparticles has been studied quite extensively using time-resolved, pulsed 
laser source measurement techniques.
70-72
 Whether a nanoparticle absorbs or scatters light is 
a function of its size: small nanoparticles, essentially within the dipole, or quasistatic, limit 
(nominally <100 nm) are completely absorptive, while with increasing size the ratio of 
absorption to scattering cross section of a nanoparticle decreases in a complex manner. 
Ultimately, larger sized (micron-scale) particles are better scatterers than absorbers of light. 
Upon resonant illumination with an ultrashort laser pulse, absorptive metallic nanoparticles 
undergo a very rapid and dramatic increase in temperature (on the subpicosecond timescale). 
First, there is an initial transient regime where the electrons are at a much higher temperature 
than the atomic lattice of the nanoparticle. Following this initial rapid heating, the electron 
and lattice temperatures of the nanoparticle equilibrate on the timescale of a few picoseconds, 
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consistent with the inverse of the highest phonon frequency in the material. Both theoretical 
and experimental studies indicate that nanoparticle surface temperatures that result can easily 
exceed the boiling point of water, sometimes by several hundreds of degrees,
69
 depending on 
the nanoparticle properties and illumination characteristics. In some cases, this can result in a 
melting/reshaping of the nanoparticle, changing its optical absorption characteristics 
irreversibly.
73-74
 If the light-absorbing nanoparticle is immersed in a medium or fluid when 
illuminated, a non-equilibrium condition will exist between the hot nanoparticle and the 
cooler surrounding medium. At very low incident powers, this still can result in remarkably 
large temperature increases in the surrounding medium due to the presence of the hot 
nanoparticle.
75
 At the lower illumination intensities of interest in biomedical applications, the 
photothermal response of the nanoparticle can result in heating of the local medium 
surrounding the nanostructure, which can be used for photothermal tumor ablation by 
inducing hyperthermia, with resultant cell death.
76
 For the light-assisted delivery of 
nucleotides, sufficient incident intensities must be used to initiate the process of DNA 
melting on the nanoparticle surface, but must be significantly below the intensities where 
photothermal cell death may result.
76-79
 
An additional property of the plasmon resonance of nanoparticles is the generation of 
nonequilibrium “hot” electron-hole pairs, a dominant mechanism for plasmon decay.80  In 
addition to damping the plasmon resonance,
66
  hot electrons can react with molecules at the 
surface of the metal nanoparticle, resulting in enhanced photoinduced charge transfer 
reactions.
81-83
 
The plasmon-resonant frequencies of metallic nanoparticles depend strongly on 
particle geometry. The plasmon-resonant frequencies of metallic nanoparticles can be tuned 
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through the interaction, or hybridization, of plasmons supported by nanostructure 
geometry.
43, 84
 This underlying principle, known as plasmon hybridization, has given rise to a 
large family of plasmonic nanoparticles whose resonances can be tuned to virtually any 
resonant frequency in the visible and infrared regions of the electromagnetic spectrum. For 
biomedical applications, a progression of Au nanostructures of various shapes and sizes has 
been developed with optical resonances in, or that can be tuned to, the near infrared (NIR) 
water window (690–900 nm).35, 85-86 Blood and tissue are maximally transparent in this NIR 
spectral window, making it optimal for biomedical applications that utilize light.
39
 
2.9. Thermal dehybridization of dsDNA 
The temperature at which melting, or dehybridization, of double-stranded DNA in 
solution occurs is influenced by many factors, including composition and orientation of 
neighboring base pairs, sequence length, and salt concentration. For example, dsDNA with a 
higher percentage of Guanine–Cytosine (GC) pairs will have a higher melting temperature, 
because the GC pair compared to the Adenine–Thymine (AT) has greater stacking 
interactions and an additional third hydrogen bond. To predict the melting temperature of 
dsDNA in solution, the nearest neighbor (NN) model is used to determine nucleic acid 
stability based upon the composition and orientation of neighboring base pairs.
87-91
 The NN 
model is based largely on experimental work over more than two decades that provided 
precise measurements of thermodynamic parameters.
92-98
 These included specifically the 
binding free energy (ΔG), enthalpy (ΔH), and entropy (ΔS) for the 10 possible neighboring 
base pair combinations: AA/TT, AT/TA, TA/AT, CA/GT, GT/CA, CT/GA, GA/CT, CG/GC, 
GC/CG, GG/CC. So, by knowing the composition of dsDNA, the predicted ΔG can be 
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calculated by summing the ΔGn values of each neighboring base pair plus a ΔG initiation 
value (ΔGint). 
  nintPredicted GGG
 
(2-1) 
Similarly, ΔH and ΔS are calculated and used to predict the melting temperature (Tm) 
of complementary oligonucleotides. The total oligonucleotide strand molar concentration 
(CT), and the theoretical ΔH and ΔS, are used: 
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where R is the gas constant (1.987 cal K-1mol-1) [47]. The salt concentration also 
plays a critical role in dsDNA melting temperature. The Tm increases with increasing salt ion 
concentration due to the salt ions shielding the Coulombic repulsion between the negatively 
charged phosphate backbones of the oligonucleotides. If the salt ion concentration is low, the 
shielding decreases, so the dsDNA becomes less stable and the Tm decreases. There has been 
much debate whether the salt effect is sequence or length dependent; however, the most 
accurate empirical equation is a quadratic salt correction function that is sequence, 
composition, and length dependent.
99
 Because of this extensive research effort, the Tm of 
dsDNA in solution is considered to be a relatively straightforward-to-predict value. However, 
binding dsDNA to nanoparticle surfaces for either thermal or light-induced release introduces 
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a new local environment for the DNA molecules which dramatically modifies solution-phase 
Tm values. 
2.10. Au nanoparticle-based vectors for gene therapy 
DNA can be bound to Au nanostructures by simple thiol chemistry or electrostatic 
attachment. DNA attached to Au nanostructures has an increased half-life from minutes to 
hours against attack by large nucleases due to the increased steric hindrance caused by 
attachment to the Au surface.
27
 Additionally, polyvalent cations near the Au nanoparticle 
surface electrostatically repel dications located within the nucleases, also increasing 
oligonucleotide stability.
100
 
Increasing the cellular uptake efficiency of therapeutic DNA is necessary for effective 
therapy. The attachment of either therapeutic oligonucleotides (DNA, siRNA) or existing 
transfection agents (cationic liposomes, cationic polymers, and dendrimers) to Au 
nanoparticles has been shown to universally increase cellular uptake and transfection 
efficiency. DNA/siRNA molecules condense when attached to the Au surface. Attaching 
other non-viral gene delivery vectors, such as lysine dendrimers, to Au nanoparticles has 
been shown to increase gene transfection 28-fold relative to the dendrimer alone.
57
 Following 
cellular uptake, the oligonucleotides must be able to escape from the endosome, diffuse 
through the cell, and interact with the cell’s genetic material. Currently, subsequent to 
cellular uptake, the DNA-bearing carriers are believed to be sequestered in the endosome. It 
is currently hypothesized that the use of light activated plasmonic nanostructures can 
effectively disrupt the endosome and release the DNA into the interior of the cell. Wu et al. 
have observed that light-induced endosomal disruption occurs with pulsed laser irradiation, 
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and suggested that transient cavitation of vapor microbubbles that form between the 
temperature gradient on the surface of the plasmonic Au nanoparticle and the surrounding 
medium are responsible for this disruption.
101
 
A summary of different Au nanostructure-based gene therapies reported to date is 
shown in Table 2-1. Cellular delivery of DNA/RNA conjugated to Au nanoparticles can be 
effectively accomplished either with or without light activation. Without light activation, 
when the Au nanostructures are merely serving as carriers for transferring genetic material 
into cells, they do elicit a therapeutic response, either downregulation,
27, 102
 or enhanced gene 
expression.
103
 In general, however, the limited yield of non-light-activated therapy limits this 
therapeutic strategy. Light-responsive delivery vectors appear to overcome these challenges 
quite effectively and may be therapeutically more beneficial for controllable gene release 
than the non-light-activated approach. 
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Type of Au 
nanostructure 
Wavelength 
of response 
(nm) 
 
DNA/RNA binding 
chemistry 
Type of 
gene 
therapy 
Therapeutic 
target 
Ref. 
Nanorods 900 
Nanorods capped with 
phosphatidylcholine 
interact with DNA 
electrostatically 
Light 
activated 
Plasmid DNA 
release 
104
  
Nanorods 780–1100 
Thiolated DNA 
covalently attach to Au 
surface 
Light 
activated 
DNA release, 
GFP gene 
expression, block 
mRNA 
translation of 
ERBB2 
64, 105-
106
  
Hollow 
nanoshells 
800 
Thiolated polyethylene 
glycol-RNA chemically 
bound to Au surface 
Light 
activated 
RNA interference 
107
  
Nanospheres 520 
Nanoparticles positively 
charged with 
dimethylethyl-
ammonium interact 
electrostatically with 
DNA. 
Light 
activated 
T7 RNA 
polymerase 
63
  
Hollow 
Nanoshell 
800  
Thiolated siRNA 
chemically bound to Au 
surface 
Light 
activated 
NF-κB p65 
downregulation 
108
 
Nanospheres 520 
Ethylene glycol-
alkylthiol modified RNA 
attach chemically to Au 
surface 
Non-light 
activated 
Firefly luciferase 
downregulation 
102
  
Nanospheres 520–560 
Plasmid DNA 
electrostatically attached 
to Au encapsulated in 
cationic liposomes 
Non-light 
activated 
Enhanced green 
fluorescent 
protein 
expression 
109
  
Nanospheres 520 
Positively charged 
aminated nanoparticles 
electrostatically attach to 
plasmid DNA 
Non-light 
activated 
Murine IL-2 
mRNA 
expression 
110
  
Nanospheres 520 
Nanoparticles bearing 
primary ammonium 
groups bind with anionic 
DNA via ion-pairing 
Non-light 
activated 
β-Galactosidase 
reporter gene 
expression 
103
  
Table 2-1. A summary of different Au nanostructures utilized for light activated and 
non-light activated gene therapy, their wavelength of response, DNA attachment 
chemistry, and therapeutic target. 
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As can be seen in Table 2-1, the combination of Au nanoparticles and light-activated 
DNA release has been recently identified by numerous groups as a potentially useful strategy 
for increased effectiveness in gene therapy. Several variations of this general approach have 
been demonstrated. DNA has been attached to functionalized Au nanoparticles via 
photoactive ester linkages, where near-UV irradiation has been used to cleave the ester 
moieties, releasing the DNA.
63
 The potential practical biomedical applicability of this 
specific approach is limited, since for in vivo applications, NIR irradiation (690–900 nm) is 
highly preferable to near-UV light due to its far deeper penetration in tissue,
111
 as well as its 
negligible mutagenicity relative to near-UV light. Therefore, plasmonic nanoparticles with 
resonances in the NIR region of the spectrum, such as nanoshells and nanorods, are 
preferentially being pursued. Nanorods either electrostatically attached to DNA
104
 or 
covalently bound to thiolated DNA through the Au–S bond105-106 were shown to release DNA 
when excited with a NIR pulsed laser at the plasmon resonance. However, ultrafast pulsed 
laser irradiation may reshape nanorods, which can modify their aspect ratio and their optical 
properties, including their resonant frequency.
106
 Modifications in the nanorod geometry will 
reduce or eliminate the NIR absorption of these nanoparticles, and could effectively turn off 
NIR light-controlled release. Moreover, in biomedical applications, the reshaping of 
nanoparticles may also modify their pharmacokinetics and biodistribution, which may affect 
their safety and delay or eliminate their ultimate approval for human use. The melting and 
reshaping of nanorods can be circumvented by using a continuous wave laser.
64
 Lee et al. 
conjugated thiol-modified dsDNA to nanorods, released the oligonucleotides upon NIR 
illumination, and successfully blocked the translation of ERBB2 mRNA in BT474 breast 
carcinoma cells. However, a very low percentage of cells showed protein downregulation: 
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further studies are warranted to quantify this response. Still, the overall strategy of near-IR 
triggered oligonucleotide release from Au nanoparticle-based vectors is highly promising.  
This collection of recently reported results is an excellent motivation for quantitative and 
mechanistic studies of the light-induced release process of DNA and siRNA from plasmon-
resonant nanoparticle surfaces.  
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Chapter 3  
 
Light-induced release of DNA from plasmon-
resonant nanoparticles: Towards light-
controlled gene therapy 
This work was done in collaboration with Aoune Barhoumi, Rizia Bardhan, Mark 
Knight, and Naomi. J. Halas at Rice University 
3.1. Introduction 
Here we develop an Au-nanoparticle-based non-viral vector for antisense gene 
delivery consisting of double-stranded DNA (dsDNA) covalently attached to NIR-absorbing, 
plasmon-resonant Au nanoshells. Light-controlled release of ssDNA from Au nanoshells 
induced by resonant light absorption is demonstrated for oligonucleotide sequences of 
differing lengths and base compositions. The dehybridization temperatures of these 
sequences have been determined experimentally for both thermal and light-controlled 
dehybridization. Light controlled oligonucleotide release is found to occur with essentially no 
temperature increase of the ambient nanoparticle solution, in stark contrast to thermal release 
which occurs at significantly higher temperatures. Both dehybridization temperatures are 
found to be significantly below the solution-phase Tm for the same oligonucleotide. The 
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maximum dsDNA coverage, as well as the percentage of DNA released from the 
nanoparticle surface, are determined for both light-controlled and thermal DNA 
dehybridization, and are found to be quite different for these processes. This work is the first 
study quantifying the effects of light-controlled DNA release from plasmon-resonant 
nanoparticles relative to thermally driven DNA release: the characteristics observed here are 
likely to provide general insight and stimulus for further study of light-induced DNA release 
from other plasmonic nanoparticles. 
Au nanoshells are spherical core–shell nanoparticles consisting of a silica core and 
Au shell with plasmon resonance frequencies controlled by the relative inner and outer radius 
of the metallic shell layer.
43, 84, 112
 Au nanoshells can be designed to have their maximum 
absorbance in the NIR region of the spectrum.
113
 This absorbance wavelength is particularly 
important for biomedical applications since it falls within the near infrared spectral water 
window where tissue is nearly transparent. When illuminated with NIR light of resonant 
wavelength Au nanoshells absorb a portion of the total electromagnetic energy incident on 
the nanoparticle complex and convert the light into heat, resulting in an increased 
temperature on the Au nanoshell surface. This nanoparticle-based light-to-heat conversion 
has been explored in other therapeutic applications, in particular for photothermal cancer 
therapy.
14
 In this investigation, we study both purely thermal and light-controlled DNA 
dehybridization for DNA bound to nanoshell surfaces. The dsDNA has two strands: (1) a 
sense oligonucleotide with a thiol group on its 5′ end for covalent bonding to the Au 
nanoshell surface, and (2) a complementary antisense oligonucleotide, which is the 
therapeutic sequence. These two complementary oligonucleotides hybridize through 
Watson–Crick base pairing. In this study, the therapeutic payload is the antisense 
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oligonucleotide (ssDNA), and the principle is the same as antisense oligonucleotide therapy 
except Au nanoshells are the therapeutic carriers and light excitation controls the ssDNA 
release. Figure 3-1 shows a schematic of the Au nanoshell-based delivery system. 
 
Figure 3-1. Schematic of light-controlled release of ssDNA from Au nanoshells. Green 
sequences are the thiolated sense sequences bound to the Au nanoshell surface, red 
sequences are the antisense sequences, released when nanoshells are illuminated with 
NIR light at their plasmon resonant frequency. 
3.2. Experimental Methods 
Au nanoshell synthesis.  Au nanoshells were synthesized according to previously 
published procedures.
35, 114
 The dimensions of the silica core (120 nm colloidal silica, 
Precision Colloids LLC, Cartersville GA) and the Au shell were chosen such that the peak 
plasmon resonance in aqueous suspension was 800 nm, corresponding to the excitation 
wavelength used in this experiment. 
Thermal and light-driven DNA release  To demonstrate thermal and light-
controlled release of ssDNA, several DNA oligomers of varying lengths and compositions 
(purchased from Integrated DNA Technology Inc.) were utilized (Table 3-1). Prior to use, all 
thiolated DNA oligomers were reduced with 1,4-Dithio-DL-threitol (DTT, Fluka) and purified 
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with NAP5 purification columns (GE Healthcare). Non-thiolated DNA sequences were used 
as received, having been HPLC-purified by the vendor. 
Oligonucleotide Sequence (5′-3′) 
ST20N1 (70 bases) 
CTGACGCTGGTTGCATCGGACGATACTACATGCCAGTTGGACT
AACGGCGGGACAGCAGCTTTTTTTTTT 
SN2 (50 bases) 
GCGGCAATCAGGTTGACCGTACATCATAGCAGGCTAGGTTGG
TCGCAGTC 
SN3 (30 bases) TATGATCTGTCACAGCTTGATACTACTTCA 
SN4 (20 bases) TATGATCTGTCACAGCTTGA 
SN3-comp (30 
bases) 
TGAAGTAGTATCAAGCTGTGACAGATCATA 
Table 3-1. DNA sequences used in this study. The released sequences are shown: the 
capture sequences are complements of these sequences with a thiol on the 5′ end to 
ensure binding to the Au nanoshell surface. Labeled-sequences are the same released 
sequences with fluorescein on the 5′ end. 
 
DNA hybridization was performed by mixing two complementary DNA sequences in 
a 1:1 M ratio in DNA hybridization buffer (TE/50 mM NaCl, pH = 7.5), heating the solution 
to 95 °C, then allowing it to cool slowly to room temperature in a large water bath. To ensure 
the maximum surface dsDNA coverage on the nanoshells, excess hybridized dsDNA was 
incubated with an aqueous suspension of Au nanoshells for at least 8 h. The dsDNA was first 
precipitated with ethanol to minimize salt concentration and avoid nanoshell aggregation. 
Before the thermal or light-assisted dehybridization of dsDNA, the DNA/nanoshell 
mixture was centrifuged at least twice and resuspended in fresh buffer to remove excess free 
DNA in solution. Light-assisted release was performed as follows: 1 ml of nanoshells/DNA 
suspension was illuminated with a continuous wave laser (DioMed, λ = 800 nm, 1 W incident 
power). The temperature of the suspension (ambient temperature) was monitored with a 
thermocouple. For non-labeled DNA sequences, 1 mL aliquots were taken at different 
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temperatures and run in a 3% agarose gel. For fluorescein-labeled DNA samples, 
fluorescence measurements of the supernatant were performed. For thermal dehybridization, 
DNA/nanoshell suspension was heated in a water bath. Similarly, aliquots were obtained and 
run in gel electrophoresis or checked for fluorescence intensity. 
DNA-nanoshell coverage and percentage release.  To quantify the number of 
oligonucleotides on the nanoshell surface, a 12 mM mercaptoethanol solution (Sigma 
Aldrich) was used as a DNA-displacing solution. Mercaptoethanol rapidly displaces 
hybridized surface-bound oligonucleotide via a thiol exchange reaction.
115
 This process is 
rapid and efficient because the oligonucleotide self-assembled monolayer (SAM) cannot 
block access of the mercaptoethanol to the Au surface. Additionally, mercaptoethanol forms 
a more tightly packed SAM due to its greater packing energy via Van der Waals forces than 
the DNA monolayer it displaces. 
First, a standard curve of fluorescein-labeled DNA fluorescence intensity versus 
DNA concentration was experimentally determined. The amount of DNA bound to the 
nanoshell surface in a sample was determined by taking a fluorescence measurement of the 
supernatant before the mercaptoethanol displacing solution was added (background 
fluorescence) and after 24 h incubation with mercaptoethanol. Subtraction of the background 
fluorescence allowed us to obtain a value for the amount of DNA displaced. Nanoshell 
concentration was determined by using the Beer–Lambert law, the extinction coefficient was 
determined by Mie theory. Finally, the amount of DNA per nanoshell was calculated. Since 
the antisense strand was tagged with fluorescein, the amount of DNA released was easily 
quantified. After thermal or light-driven release of DNA, the difference in fluorescence 
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intensity was calculated and the percentage of DNA released was determined. In these 
experiments the displacing solution was not used. 
3.3. Results and discussion 
DNA dehybridization irreversibility.  The purpose of this study was to compare the 
amount of ssDNA released by light-controlled and thermal dehybridization, and to obtain the 
effective DNA-ambient melting temperature for both processes. Dehybridization reversibility 
is a critical concern for these processes, since rehybridization of the released ssDNA back to 
the nanoparticle once the laser irradiation has ceased, if it occurs to a significant extent, 
would greatly limit the effectiveness of this strategy for gene delivery. 
In the first experiment, a suspension of Au nanoshell/dsDNA (SN3 prehybridized 
with its thiolated complement) was prepared as described. The ssDNA antisense strand has a 
fluorescein label on its 5′ end. The prepared nanoparticles were divided into two samples. For 
both samples, DNA dehybridization was thermally induced. In one sample, an excess of the 
non-thiolated SN3-complement was added to solution. In the presence of the excess of the 
SN3-complement, the released SN3 DNA will preferentially hybridize to the excess SN3-
complement in solution. For the other sample, no additional DNA was added to the solution. 
After thermal dehybridization of both samples under the same experimental conditions, the 
aliquots were centrifuged and the fluorescence intensity of the supernatant was measured. 
The released sequence was the only source of a fluorescence signal. If the released DNA 
rehybridizes with its complementary sequences left behind on the Au nanoshell surface, the 
amount of fluorescent DNA in solution will be significantly higher for the sample with the 
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excess DNA complement in solution and a measurably lower fluorescent signal when no 
SN3-complement is available in solution for competitive binding. 
The results of this experiment are shown in Figure 3-2. Here it can be seen that the 
fluorescent signal due to the released DNA agrees for the two release conditions within 
experimental error, and that the DNA dehybridization on the Au nanoshell surface is an 
essentially irreversible process. This dehybridization irreversibility is critical for biological 
applications, and must be the case for the released DNA to be delivered to proceed to mRNA 
binding, in the case of antisense oligonucleotide therapy. 
 
Figure 3-2. DNA dehybridization irreversibility. (a) Schematic depicting the released 
DNA behavior with and without complementary sequence. (b) Graph shows the amount 
of DNA released versus the temperature based on the released DNA fluorescence 
intensity with (red) and without (black) complementary sequence. 
 
Two main factors contribute to the dehybrization irreversibility. First, rehybridization 
of the released ssDNA would require it to hybridize to the complementary sequences on the 
Au surface, a process well documented to be of low efficiency.
115
 In addition, after 
dehybridization, the sense sequence on the nanoparticle surface may loop and bind non-
specifically directly onto the Au surface, preventing rehybridization. This effect would be 
likely for all metal surfaces with high affinity to DNA. It is worth noting that the presence of 
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the SN3-complement in solution did not appreciably affect either the DNA melting 
temperature (around 35 °C) or the amount of DNA released. At low temperatures, however, 
the amount of DNA released in the presence of the excess SN3-complement sequence is 
slightly higher due to non-thermal DNA release, either due to non-thermal dehybridization or 
the presence of some non-specifically bound ssDNA on the nanoparticle surface. 
Thermal release of ssDNA.  dsDNA dehybridization is an essential process in all 
biological systems as well as many DNA-based nanotechnology applications. The 
mechanism of dsDNA thermal dehybridization has been thoroughly studied.
116
 It has been 
shown that dsDNA attached to surfaces, in particular Au surfaces, behaves differently than 
free dsDNA in terms of melting temperature and phase transition.
117
 
We first studied the thermal dehybridization of dsDNA attached to Au nanoshell 
surfaces. Gel electrophoresis has been used to determine the amount of ssDNA released, a 
process requiring no fluorescent labeling of the DNA. In the 3% agarose gel used in this 
work, the pore size is much smaller than the nanoshell diameter. Consequently, the 
nanoshells in the DNA/nanoshell suspension are trapped in the gel electrophoresis wells. 
Only free DNA will migrate through the gel matrix. Comparing the bands intensities of the 
released ssDNA from aliquots taken at different temperatures reveals the progression of the 
DNA release in the DNA/nanoshell sample, since the band intensity is proportional to the 
concentration of DNA. 
DNA melting curves, obtained by monitoring the UV fluorescence (from the DNA-
associated dye Syber green) in the gel column as a function of solution-ambient temperature, 
are shown for thermal DNA dehybridization (Figure 3-3a) and for light-induced DNA 
dehybridization (Figure 3-3b). The UV absorption intensity is directly proportional to the 
35 
 
 
 
amount of DNA released. The maximum of the first derivative of these curves, 
corresponding to the temperature of maximum DNA release, is defined as the DNA melting 
temperature, Tm. For both thermal and light-induced DNA release, the derivative plots are 
shown as insets. The melting temperature of the 20 base dsDNA (SN4 with its thiolated 
complement] attached to Au nanoshells was experimentally determined to be 37 °C (Figure 
3-3a). The melting temperature of the same dsDNA sequence in solution, not confined to Au 
surface, is expected to be nominally 50 °C at 50 mM salt concentration (IDT DNA). 
Although the salt concentration on the nanoshell/DNA solution is likely to be somewhat 
lower than 50 mM due to ethanol precipitation of the DNA prior to binding to the nanoshell 
surfaces, there is still clearly a significant decrease in the DNA melting temperature when 
DNA is bound to the Au surface relative to the anticipated solution-phase Tm. The same trend 
was consistent for all DNA sequences investigated in this study. It is interesting to note that 
DNA melting temperature depression for DNA bound to an Au surface is still a matter of 
debate: both increasing and decreasing Tm for DNA on Au nanoparticles relative to the 
corresponding solution phase value have been reported.
117-118
 
Under the experimental conditions described above, the Tm of the dsDNA sequence 
attached to Au nanoshell surfaces has shown a significant decrease.
117
 Most likely, the high 
affinity of DNA to the Au surface is playing an essential role in the Tm reduction. In solution, 
the Tm depends solely on DNA strand length and base composition. However, when one 
strand of the duplex is attached to a surface, the Tm may be affected by the influence of the 
surface on the duplex stability. Because of the high affinity of ssDNA to the Au surface, the 
single-stranded DNA form is more favorable than when in solution, which would result in a 
decrease in DNA melting temperature. 
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Light-induced release of ssDNA.  The DNA melting curve for light-induced DNA 
dehybridization is shown in Figure 3-3b, with the first derivative of the melting curve shown 
in the inset. Here the Tm of the 20 base DNA sequence, the same sequence used in thermal 
dehybridization, is 27 °C. This corresponds closely to the ambient temperature of the DNA-
nanoshell suspension. This lack of temperature increase corresponds to two possible 
mechanisms for DNA release. These are: (1) a non-equilibrium thermal mechanism, where 
the irradiated nanoparticle undergoes a strong and rapid temperature increase at its surface 
sufficient to melt the DNA but not sufficient to raise the ambient solution temperature, or (2) 
a non-thermal mechanism, such as charge transfer to the DNA adsorbate, resulting in DNA 
dehybridization driven by Coulomb repulsion. Further experimentation would be needed to 
specifically identify which mechanism or mechanisms may be responsible for the DNA 
release. 
 
Figure 3-3. Thermal (a) and light-induced (b) release of ssDNA from dsDNA-coated 
nanoshells in solution. The melting curves for 20 base dsDNA attached to Au nanoshell 
surface are shown. Insets show the first derivatives of the melting curves, depicting the 
melting temperatures Tm of each process. 
 
To examine this ambient-temperature light-induced dehybridization further, both 
thermal and light-assisted dehybridization experiments were performed on three other 
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sequences (30, 50, and 70 bases). Correspondingly, similar distinct decreases in the Tm due to 
thermal dehybridization and to light-assisted dehybridization of dsDNA attached to 
nanoshells were observed (Figure 3-4). For all sequences studied, light-assisted DNA 
dehybridization is observed to occur at essentially ambient temperature. While further studies 
are warranted to determine the specific light-induced release mechanism, the fact that release 
occurs at ambient temperature over a range of oligonucleotide lengths and compositions is 
extremely encouraging for gene therapy applications. The fact that laser-induced gene release 
can occur in a regime where the laser irradiation does not increase the ambient temperature 
indicates that this process may be useful for the safe release of oligonucleotides in cells 
without inadvertently compromising cell viability. 
 
Figure 3-4. Comparison of the light-induced (green) versus thermal (red) 
dehybridization of dsDNA sequences of different lengths tethered to Au nanoshells. For 
all DNA sequences studied, the light-assisted melting temperatures are lower than 30 °C 
which makes this system suitable for releasing ssDNA as long as 70 bases in biological 
applications. 
 
Surface coverage and percentage release.  DNA surface coverage on nanoshells 
was determined using a previously reported protocol with minor modifications.
115
 In this 
procedure, (i) the concentration of nanoshells is determined from the extinction spectra and 
Mie theory, (ii) the emission intensity of fluorescence-labeled DNA displaced from the 
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nanoshell surface is measured, and (iii) the fluorescence intensity is correlated to the DNA 
concentration through a standard, previously determined curve. The number of molecules 
and the percentage of ssDNA released from the nanoshell surface can be determined by 
comparing the fluorescence intensity before and after thermal or light illuminated DNA 
release. 
The coverage of dsDNA molecules on Au nanoshells was determined to be 6400 
dsDNA molecules/nanoshell which corresponds to 14.6 pmol/cm
2
. This coverage is 
consistent with previous results of oligonucleotide surface coverage on Au films 
(18.1 ± 3 pmol/cm
2
).115 Due to the 150 nm diameter size of the NS particle, its surface is 
more analogous to a Au film compared to a small Au nanoparticle. This observation is 
consistent with published results indicating that the packing density of oligonucleotides on 
the surface becomes analogous to packing densities on a Au film when a spherical Au 
nanoparticle substrate approaches 150 nm in diameter.
119-120
 The decrease in packing density 
determined for DNA on nanoshells relative to that reported for planar Au surfaces may be 
due to (1): the use of dsDNA in our studies instead of ssDNA, and (2) a decreased salt 
concentration needed to prevent nanoshell aggregation, which reduces electrostatic repulsion 
between DNA chains and decreases overall packing density.
115
 
The percentage of DNA released was determined for the cases of both thermal and 
light-induced DNA dehybridization. While ~90% of the ssDNA is released for thermal 
dehybridization, only ~50% of the total available ssDNA is released for the light-induced 
process. The fact that these release percentages are so remarkably different provides strong 
support for a fundamental difference between the thermal and light-induced DNA 
dehybridization process. While it is not surprising that the thermal release process, conducted 
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under equilibrium conditions, results in the greatest percentage of ssDNA released from the 
nanoshell surface, it raises significant further questions regarding the actual release 
mechanism or mechanisms involved in light-driven DNA release. It is also important to note 
that the number of ssDNA molecules released per nanoshell in the case of light-induced 
release (3169 ssDNA/nanoshell) is considerably larger than the number of molecules 
released by the same process on nanorods (250 molecules/nanorod).
64
 This possible 
dependence of yield on the aspect ratio of the nanoparticle also suggests that this process 
occurs under highly non-equilibrium conditions on the nanorods surface, or that a charge-
transfer mechanism may be important in the release process. 
3.4. Conclusions 
Both thermal and light-triggered dehybridization of dsDNA, wherein one 
complementary strand was covalently bound to Au nanoshells, was investigated. In contrast 
to dehybridized ssDNA in solution, dehybridization of dsDNA bound to an Au nanoparticle 
surface is shown to be essentially irreversible. The melting temperatures of dsDNA bound to 
nanoshell surfaces was assessed for both thermally-induced and resonant light-induced 
dehybridization. A large difference in Tm was observed for each process, and each process 
occurs at a Tm substantially lower than the corresponding melting temperature of the same 
oligonucleotide in solution. 
The light-induced dehybridization of dsDNA bound to Au nanoshells appears to 
occur at the solution-ambient temperature for all dsDNA sequences and lengths studied. The 
coverage of dsDNA on Au nanoshell surfaces was quantified and shown to correspond 
closely to packing densities obtainable on planar Au films. By quantifying surface coverage 
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of dsDNA, we were also able to determine the percentage of ssDNA released for both the 
thermal (∼90%) and the light-induced (∼50%) release process. These studies point to some 
very interesting and dramatic differences between thermal and light-induced processes on 
plasmon-resonant nanoparticle surfaces. Not only does this system provide a promising 
potential for light-controlled gene release for gene therapy, it also provides a new and 
exciting context where the rich chemical physics of substrate–adsorbate interactions may 
prove relevant to our understanding of light-actuating nanoparticle complexes. 
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Chapter 4 
 
Light-Induced Release of DNA from Au 
Nanoparticles: Nanoshells and Nanorods 
This work was done in collaboration with Jorge Zuloaga, Mark W. Knight, Lisa V. 
Brown, Peter Nordlander, and Naomi J. Halas at Rice University. 
4.1. Introduction 
For many reasons, Au nanoparticle-based complexes show great promise for a wide 
variety of biomedical applications.  Their small size relative to eukaryotic cell dimensions 
facilitates intracellular uptake (endocytosis), providing an effective method for the 
transfection of adsorbate “cargo” molecules into the intracellular environment.  Au 
nanoparticle surfaces can be readily functionalized with thiolated molecules, taking 
advantage of the strong Au-S bond, enabling the formation of functional nanocomplexes.  
This “Au nanoparticle + molecular layer” platform provides a general functional strategy for 
designing nanocomplexes with specific, and often multiple, functionalities.  Examples of 
functional or multifunctional nanocomplexes constructed in this manner include enhanced 
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fluorescence and MRI contrast agents for bioimaging, delivery vectors for molecular 
chemotherapeutics or oligonucleotides for gene therapy.  
10, 57, 121-122
  
 Au-based nanoparticles of various morphologies offer additional functionality 
because of their optical properties, derived from the characteristics of their localized surface 
plasmon. Examples of Au-based nanoparticles of interest for biomedical applications include 
nanoshells, nanorods,  nanocages, and other geometries,
86, 123-129
 that allow the plasmon 
resonance to be shifted from the visible into the physiological “water window” in the near 
infrared region of the spectrum.
39
  Illumination at their plasmon resonant frequency results in 
light absorption, where the absorbed energy is efficiently converted to heat and can be 
exploited for hyperthermal cancer therapy
130-131
 or photothermal drug delivery.
31, 101, 105, 122
  
Plasmonic nanoparticles larger than the dipole (i.e., quasistatic) limit are also highly effective 
light scatterers, a property advantageous for bioimaging.
132
  Additionally, plasmonic 
nanoparticles can modify the optical density of states of nearly adjacent fluorophores, 
decreasing their radiative lifetime and increasing their quantum yield, enhancing their 
fluorescence.
12, 133-136
  This property is particularly advantageous for bioimaging, since it can 
be used to improve the quantum yield of fluorophores already in widespread use, enhancing 
popular imaging modalities such as optical tomography.
137-138
 An additional property of the 
plasmon resonance of nanoparticles, frequently overlooked, is the generation of 
nonequilibrium “hot” electron-hole pairs, a dominant mechanism for plasmon decay.80  In 
addition to damping the plasmon resonance,
66
  hot electrons can react with molecules at the 
surface of the metal nanoparticle, resulting in enhanced photoinduced charge transfer 
reactions.
81-83
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The light-triggered, remotely controlled release of oligonucleotides from plasmonic 
nanoparticle-based complexes is an important application that has recently begun to be 
investigated.  Thus far, light-induced release has been demonstrated using two general 
strategies.  One approach consists of attaching the cargo molecules to be delivered directly to 
the nanoparticle surface, typically through a Au-thiol bond, then using femtosecond laser 
pulses to reshape the nanoparticles and break the Au-S bond.
31, 104-106
  This approach presents 
significant risk for in vivo applications: the incident energy sufficient to reshape plasmonic 
nanoparticles may very well be sufficient to induce cell death, and the smaller sized 
nanoparticles resulting from this process have been shown to have toxic effects. 
139-140
  In the 
second method, a “host” molecule is first attached to the nanoparticle surface, typically via a 
Au-thiol bond, then the cargo molecule is complexed, not to the nanoparticle surface, but to 
the host molecule via weaker, noncovalent interactions.  When this type of nanocomplex is 
illuminated with light at a wavelength corresponding to the plasmon resonance of the dressed 
nanoparticle,
64, 122, 141-142
 the attraction between host and cargo species is reduced and the 
therapeutic molecules are released.  This release strategy shows excellent promise for light-
controlled delivery due to the relatively low laser power densities and short irradiation times 
required to achieve release of molecular cargo. 
Recently we demonstrated light-induced release of single-stranded deoxyribonucleic 
acid (ssDNA) from plasmonically tunable Au nanoshells, nanoparticles consisting of a 
spherical silica (SiO2) core surrounded by a Au shell.
143
  Nanoshells with their plasmon 
resonance wavelength at 800 nm were coated with double-stranded DNA (dsDNA), where 
one strand of the DNA possessed a terminal thiol moiety on its 5’ end for attachment to the 
nanoshell surface.  In this configuration, one strand of the DNA serves as the host molecule.  
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The complementary DNA cargo sequence hybridized to the host molecule was nonthiolated, 
and therefore, when hybridized, was bound only to its DNA complement host and not the 
nanoparticle surface.  Upon 800 nm laser illumination, the dsDNA was dehybridized, 
releasing the nonthiolated ssDNA sequence.  The properties of light-induced DNA release 
performed in this manner were compared to that of thermally induced DNA release, where 
the nanocomplex solution was immersed in a thermal bath and the amount of DNA released 
as a function of solution ambient temperature was observed.
143
  Several striking differences 
between light-induced release and thermally induced release of ssDNA from this 
nanocomplex can be observed.  For the light-induced case, DNA release occurs with minimal 
increase in solution ambient temperature, and appears largely independent of oligonucleotide 
length in the 20-70 base pair range.  Thermally-induced release occurs at the DNA melting 
temperature, which is dependent upon oligonucleotide and composition, attachment to the 
nanoparticle surface, and properties of the solution, such as ion and nanoparticle 
concentration. Another marked difference between light-induced and thermally-induced 
release is the efficiency of DNA release.  In the light-induced case, only a fraction of the 
ssDNA loaded onto the nanocomplexes is released, whereas for thermal release, virtually all 
the ssDNA cargo is released when the solution ambient temperature is increased above the 
DNA melting temperature.  These contrasting properties prompt questions regarding the 
light-induced ssDNA release process, and motivate the current study. 
 Here we directly compare the light-induced and thermally-induced release of 
ssDNA from two different types of plasmonic nanoparticles:  Au nanoshells and Au 
nanorods.  Both types of nanoparticles were designed and synthesized with spectrally 
overlapping plasmon resonances.  The release of ssDNA from both types of nanocomplexes 
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was quantified for both light-triggered and thermally induced ssDNA release.  For light-
induced ssDNA release from nanoshells, both light-induced and thermally induced 
contributions to ssDNA release are distinctly observable as the solution ambient temperature 
increases due to laser heating.  This release profile allows us to discriminate clearly between 
the light-induced and thermally induced contributions to ssDNA release in the light-induced 
case.  For nanorod-based complexes, both light-induced and thermally induced ssDNA 
release show virtually the same thermal profile, with a clear threshold for DNA release 
occurring at the DNA melting temperature in all cases.  This contrast between nanoshell-
based and nanorod-based light-induced ssDNA release can be interpreted in terms of an 
additional, nonthermal contribution that assists ssDNA dehybridization in the light-induced 
case.  In our experiments, this contribution appears to be more efficient for nanoshell-based 
complexes than for the nanorod-based complexes investigated. 
4.2. Experimental 
Au Nanoshell Fabrication.  Au nanoshells were synthesized according to previously 
published procedures.
35, 129
 The dimensions of the silica core (120 nm colloidal silica, 
Precision Colloids LLC, Cartersville GA) and the Au shell were chosen such that the peak 
plasmon resonance in aqueous suspension was 800 nm, corresponding to the laser excitation 
wavelength used in this experiment. 
Au Nanorod Fabrication.  Au Nanorods were synthesized using a previous 
published CTAB seed-mediated growth method.
44
  To make seed solution, 0.25 mL of 0.01M 
HAuCl4 was mixed with 7.5 mL of 0.1M CTAB solution.  Under vigorous stirring, 0.6 mL of 
ice-cold 0.01M NaBH4 was quickly added.  The solution turns from an amber yellow color to 
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a pale brown color. It is essential that the temperature of NaBH4 is maintained at ~0 °C prior 
to mixing with CTAB and HAuCl4 for proper growth of nanorods. This solution was stored 
in a water bath at 27°C until further use.  To make growth solution, 475 mL of 0.1M CTAB 
was combined with following solutions under slow stirring in the following order: 20 mL of 
0.01M HAuCl4, 3mL of 0.01M AgNO3, 3.20 mL of 0.1M Ascorbic acid.  Addition of the 
Ascorbic acid changes the solution from yellow to colorless.  Finally, 3.60 mL of the seed 
solution was added to the growth solution, then it was removed from the stirring plate and 
placed in a 27°C water bath for 2 hours.  The reaction was both stopped and the nanorods 
were concentrated by centrifugation (6600 rcf, 20 min) and finally resuspended to 16 mL in 
Milli-Q water. 
Ligand Exchange of Nanorods.  The CTAB on the nanorod surface was replaced 
with mercaptohexanoic acid (MHA) using a previously reported roundtrip phase transfer 
ligand exchange method.
106, 144
 First the CTAB is replaced with dodecanethiol (DDT): 4 mL 
of the nanorod solution is placed in a glass vial and pure DDT is added on top.  Upon the 
addition of acetone, the nanrods are extracted into the DDT organic phase by swirling for a 
few seconds.  The aqueous phase becomes clear indicating ligand exchange.  Next, the DDT 
organic phase is diluted with toluene and centrifuged to remove the excess DDT.  Methanol 
may be needed to precipitate the nanorods prior to centrifugation.  The supernatant was 
pipetted off and the DDT coated nanorods were resuspended in 2-3 mL of toluene by bath 
sonication for ~1 min.  These DDT coated nanorods were then added to 9 mL of 0.01M 
MHA in toluene at ~80°C and vigorously stirred.  Reflux and stirring continued until visible 
aggregation of the nanorods occurred (~10-12 min), which indicates that MHA has replaced 
the DDT, because MHA is insoluble in toluene.  The solution was then allowed to cool to 
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room temperature, washed twice with toluene and once with isopropanol via decantation.  
The isopropanol deprotonates the carboxylic acid.  The aggregates resuspended in 1x Tris-
Borate-EDTA (TBE) buffer. 
DNA Functionalization of Nanoshells and Nanorods.  DNA was hybridized by 
combining a thiolated sequence (5’- HS - (CH2)6 - TCAAGCTGTGACAGATCATA 3’) with 
its complementary sequence that was tagged with a fluorophore on the 5’ end (5’- 
FLUOROSCEIN-TATGATCTGTCACAGCTTGA-3’) in a 1:1 M ratio.  DNA hybridization 
was performed in DNA hybridization buffer (TE/50 mM NaCl, pH = 7.5).  The solution was 
heated to 95°C then allowed to cool slowly to room temperature in a large water bath.  The 
dsDNA was then precipitated with ethanol to minimize salt concentration and avoid 
nanoshell aggregation.   For attaching dsDNA to nanoshells and to ensure the maximum 
surface dsDNA coverage on the nanoshells, excess hybridized dsDNA was incubated with an 
aqueous suspension of Au nanoshells for at least 8 h.  The excess DNA was removed by 
centrifugation and the dsDNA-NSs were resuspended in 1x TE buffer (IDT, pH 7.5) For 
attaching dsDNA to nanorods charge screening is necessary to shield the negative charge of 
the phosphate backbone on the dsDNA with the negative charge on the ligand exchanged 
nanorods, which have mercaptohexanoic acid on them.  This charge screening was performed 
using previously published methods.
106, 144
 The excess DNA was removed by centrifugation, 
and then the nanorods-dsDNA were resuspended in 1x TE buffer (IDT, pH = 7.5).   
Thermal Treatment.  A 3mL solution of the NS-dsDNA sample was placed in a 
centrifuge tube, then the centrifuge tube was placed in a water bath and the water bath was 
heated slowly (~1°C/minute) while stirring.  The slow heating and stirring ensures that the 
NS-dsDNA sample is in thermal equilibrium.  The solution temperature is monitored by a 
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thermocouple.  The dehybridization and release of the fluorescein-tagged ssDNA is 
monitored by taking aliquots out of the solution as the solution temperature rises.  Each 
aliquot is allowed to cool and then centrifuged, which separates the released DNA from the 
NSs.  For each aliquot, the fluorescence intensity of the supernatant is measured, then by 
using a standard curve of fluorescence intensity versus DNA concentration, the concentration 
of DNA is quantified.  Finally, dividing the DNA concentration by the nanoshell 
concentration, which is obtained from a UV-Vis extinction measurement, results in a 
quantitative DNA release curve.   
Red Laser Treatment.  Setup was the same as the thermal treatment, except the 
centrifuge tube was not placed in a water bath.  The volume in all experiments was kept 
constant because the release of DNA was monitored as a function of solution temperature.  
Keeping the volume the same insures that any changes in the rate of heating are a result of 
the photothermal properties of the nanoparticle and not the volume of solution.  For the 800 
nm laser a DioMed 15 Plus Laser was fiber coupled.  The end of the fiber couple was placed 
above the sample (Power 1 W, Spot size Diameter = 1 cm, Optical Intensity = Power/Beam 
Cross section = 1.3 W/cm
2
). 
Green Laser Treatment.  Setup was the same as the Red laser treatment.  A 
Coherent Verdi 532 nm laser was used (Power = 1W, Spot size Diameter  = 2.25 mm, 
Optical Intensity= 25 W/cm
2
).   
Near-field Calculations. Near-field optical properties were calculated using a 
commercially available Finite-Element Method (FEM) package (COMSOL Multiphysics 
3.5).    The total electric field was calculated in the frequency domain using the RF module. 
 The particles are defined to have a Au dielectric function as determined by Johnson and 
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Christy.
145
  The particles were embedded in a surrounding spherical volume of water 
(eps=1.77).  The surrounding medium is in turn embedded in a spherical perfectly matched 
layer (PML).  The particles were excited with a plane wave.  The simulation space is 
discretized into tetrahedral finite elements.   The mesh size, simulation space volume, and 
PML thickness are chosen so that further changes in them do not affect the simulation results. 
Instrumentation. Scanning electron microscope (SEM) images were obtained using 
a FEI Quanta 400 environmental SEM at an accelerating voltage of 25 k.  Transmission 
electron microscope (TEM) images were taken using a using a JEOL JEM-2010 TEM.  
Extinction spectra were obtained using a Cary 5000 UV/Vis/NIR spectrophotometer. 
Fluorescence emission were obtained using Jobin Yvon Fluoromax 3. 
Total Extinction Cross Section.  Total Extinction Cross Section = Particle 
concentration (Particles/mL) x Volume (cm
3
) x theoretical extinction cross 
section/nanoparticle (cm
2
). Theoretical Extinction cross section for nanoshell = 1.277x10
-13
 
m
2
 and for nanorods = 3.75x10
-14
m
2
.
146
  For all experiments the total extinction cross section 
was normalized and checked experimentally by taking a UV-Vis of the solutions to confirm 
that both Nanoshell and nanorod solutions had the same extinction value.   
4.3. Results and Discussion 
Synthesis and Characterization of Au Nanoshells and Au Nanorods.  Both Au 
nanorods and Au nanoshells are prime examples of nanoparticles whose properties are 
geometrically tunable across a range of wavelengths in the visible and near-infrared regions 
of the spectrum.  Nanorods have two primary plasmonic modes, whose excitation is sensitive 
to the polarization of incident light: the transverse mode, where the collective electronic 
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oscillation of the plasmon occurs perpendicular to the major axis of the nanoparticle, and the 
longitudinal mode, where the plasmon oscillation occurs parallel to the major axis of the 
nanoparticle.  While the resonance wavelength of the Au nanorod transverse plasmon is 
similar to that for Au colloid (~520 nm), the longitudinal resonance wavelength increases 
with increasing aspect ratio.
45
  Similarly, for nanoshells, the wavelength of the plasmon 
resonance can be tuned from the visible into the near-infrared by varying the thickness of the 
Au shell relative to the size of the silica (SiO2) core. 
43
  
The nanoparticles used in this series of experiments are shown schematically in 
Figure 4-1A.  Silica core/Au shell nanoshells were synthesized using previously published 
methods.
35
  A scanning electron microscope (SEM) image of [r1, r2] = [60, 76] nm 
nanoshells is shown in Figure 4-1B.  The core and shell radii were obtained from particle size 
statistics obtained from SEM images of over 100 silica core particles and 100 Au-coated 
nanoshells.  Au nanorods were synthesized according to the seed-mediated growth method 
using Cetyltrimethylammonium Bromide (CTAB) as a surfactant.
44
 This method results in 
nanorods with high yields and a low polydispersity,  to ensure uniform nanoparticle-to-
nanoparticle plasmon resonance wavelengths.  A representative transmission electron 
microscopy (TEM) image of [w, l] = [13, 47] nm nanorods is shown in Figure 4-1C.  These 
length and width measurements are from particle size statistics of over 100 nanorods from 
TEM images.  The extinction spectra of the nanoshells and nanorods synthesized for these 
experiments are shown in Figure 4-1D.  The extinction maximum of nanoshells was observed 
at 797nm, and that of nanorods was observed at 788 nm, well within the broader spectral 
envelope of the nanoshell plasmon resonance.  For all experiments, the optical density of the 
samples were adjusted to be equivalent at the laser wavelength of 800 nm  For the 
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nanoparticles used, the extinction cross section of a nanorod is nearly an order of magnitude 
smaller than that of a nanoshell, therefore maintaining a constant optical density required a 
higher nanorod concentration relative to nanoshells.  To adjust the optical density of the two 
solutions to be roughly equivalent for both samples, we used a concentration of 30 pM for 
nanoshells and 1 nM for nanorods.  Keeping the optical density equivalent for both samples 
allows quantitative comparisons of light-triggered release for both nanoparticle 
morphologies. 
 
Figure 4-1. .  (A) schematic of nanoshells ([r1, r2] = [60, 76] nm) and nanorods ( [w, l] = 
[13, 47] nm) used in this series of experiments.  (B) SEM image of nanoshells and (C) 
TEM image of nanorods.  (D) Extinction spectra of solution of (i) nanorods with (λmax ≈ 
788 nm) and (ii) nanoshells with (λmax ≈ 797 nm).  Spectra are slightly vertically offset 
for clarity. 
 
Attachment of DNA to Au nanoshells and Au nanorods.  Both types of nanoparticles were 
functionalized with DNA oligonucleotides.  In both cases, the cargo sequence is tagged with 
a fluorescein molecule in order to quantify nanoparticle surface coverages and ssDNA 
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release. The host and cargo DNA were hybridized, then bound to the nanoparticle surfaces 
via the thiol modification on the host DNA. The nanoshells were incubated with hybridized 
dsDNA as previously reported.
143
  Hybridized dsDNA was attached to the nanorods by using 
a roundtrip phase transfer ligand exchange method
144
 (See Methods section).  Nanorods 
require a different functionalization protocol because of the need to displace residual CTAB 
molecules remaining on the as-synthesized nanorods following growth.  This method allows 
dsDNA functionalization of nanorods without any harsh sonication or heating steps that other 
functionalization methods require.  For both nanoshells and nanorods, the same 20-base 
dsDNA sequence is used (see Methods section).   
To confirm dsDNA attachment to both the nanoshells and nanorods, mercaptoethanol 
was used to displace the dsDNA.
115
  After displacement, the sample was centrifuged to 
separate the displaced DNA from the nanoparticles, a necessary step to isolate the 
fluorescently-tagged DNA from the Au nanoparticles, since fluorescence quenching or 
enhancement may occur.  The fluorescence of the supernatant was measured, and the amount 
of DNA displaced was quantified.  Dividing by the nanoparticle concentration, obtained from 
UV-Vis extinction measurements, yields the number of DNA molecules released per 
nanoparticle.  For nanorods, the surface coverage is ~40 dsDNA per nanorod (normalized by 
surface area is ~ 4.4 pmol/cm
2
); for nanoshells the coverage is approximately ~5000 dsDNA 
per nanoshell (~11.5 pmol/cm
2
).  The lower surface coverage observed for nanorods is a 
result of a much smaller surface area per nanoparticle (the nanorod surface area is nominally 
33 times smaller than the nanoshell surface area), and is also due to the difficulty of 
functionalizing nanorods  caused by the bilayer of CTAB surfactant surrounding the Au 
nanorod in solution, which limits coverage for dsDNA functionalization. Although CTAB-
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free synthesis methods exist, they typically have a significantly higher degree of 
polydispersity and therefore significant inhomogeneous broadening of the spectral lineshape, 
and were therefore not pursued for this series of experiments.  
Light-induced and thermal release of cargo DNA from Au Nanoshells. Thermal 
treatment consists of placing a 3 mL solution of the nanoshell-dsDNA sample in a centrifuge 
tube, placing the centrifuge tube in a water bath and heating the water bath slowly 
(~1°C/minute) while stirring.  The slow heating and stirring ensures that the nanoshell-
dsDNA sample is in thermal equilibrium during the entire course of the measurement.  Laser 
treatment consists of placing a 3mL solution of the nanoshell-dsDNA sample in a centrifuge 
tube, then irradiating the sample with a continuous wave NIR laser (λLASER = 800 nm, 1.3 
W/cm
2
) at the peak plasmon resonance of the nanoshell while stirring the sample.  Due to the 
photothermal properties of nanoshells, this laser excitation also results in bulk heating of the 
solution.  In both thermal and laser treatments, the solution temperature is monitored by a 
thermocouple.  The dehybridization and release of the fluorescein-tagged ssDNA is 
monitored by removing aliquots from the solution as the solution temperature rises.  Each 
aliquot is centrifuged to separate the released DNA from the nanoparticles, and the 
fluorescence intensity of the supernatant is monitored to determine the number of ssDNA 
molecules released per nanoparticle.   
A schematic of the release of DNA from Au nanoshells is shown in Figure 4-2A, 
where the host DNA sequence is shown in red, and the cargo DNA sequence is depicted in 
blue.  A comparison of light-induced and thermally induced DNA release from nanoshells is 
shown in Figure 4-2B.  The thermally induced release (Figure 4-2B, black squares) is 
characteristic of DNA melting, with a sharp onset at the effective DNA melting temperature.  
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The melting temperature of DNA is determined as half the increase in released DNA, which, 
for the nanocomplexes shown here, occurs at 60
o
 C.  By comparison, light-induced DNA 
release (Figure 4-2B, red circles) results in a quite different DNA release curve.  A 
significant fraction of the DNA is released at solution temperatures well below the DNA 
melting temperature.  Approximately 20% of the DNA was observed to be released below 
the melting temperature threshold.  The inset shows an expanded view of the temperature 
range below that of the DNA melting temperature range.  For ambient solution temperatures 
above 50°C, DNA release is extremely similar for both heating mechanisms. 
  The percentage of DNA released under illumination appears highly reproducible 
within each prepared batch, yet varies at the batch-to-batch level in the nominal range of 20-
50% over a range of experimental factors, depending upon nanoshell concentration, 
illumination geometry, and adsorbate concentration and structure.
117, 143
  We also observe 
that the thermally induced release, which results in nearly 100% DNA release, shows batch-
to-batch variations in the DNA melting temperature that vary based on nanoparticle and 
adsorbate concentration.  To ensure that the Au-thiol bond was not broken in these 
experiments, a control experiment was performed in which a fluorescently tagged thiolated 
single-stranded DNA sequence was attached to Au nanoshells.  Under identical thermal and 
laser treatment conditions, the release of this thiolated ssDNA was not observed, which 
demonstrated the Au-thiol bond is not broken as a result of either the thermal or laser 
treatments (Appendix A, Figure A-1).   
The amount of time required for the entire heating process in the laser treatment is 
approximately 12 minutes (top axis, Figure 4-2B), however, the light-induced release begins 
immediately, making this method suitable for controlled delivery of therapeutic molecules.  
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The time scale is not linear:  at higher temperatures, more time is required to heat the 
solution, due continuous heat loss by the experimental container to the surroundings during 
the course of the experiment.   
 
Figure 4-2. Thermal and Light-Triggered release of ssDNA from nanoshells .(A) 
Schematic of ssDNA release from Au nanoshells.  The thiolated host sequence (red) 
attaches to the Au surface.  The cargo complementary sequence (blue) is tagged with a 
fluorescein molecule (green).  Upon heating (thermal treatment) or illumination with 
laser light (laser treatment) the fluorescein-tagged sequence is released and 
subsequently separated from the nanoshells by centrifugation.  The fluorescence is then 
measured and normalized by nanoshell concentration. (B) Number of DNA strands 
released per nanoshell as a function of solution temperature for thermal treatment 
(black squares) and laser treatment (red dots). The inset shows the expanded view of 
the temperature range prior to thermal melting where light-triggered release is 
observed. 
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Light-induced and thermal release of cargo DNA from Au Nanorods. The light-
induced release of DNA from nanorods (Figure 4-3A) was investigated with an identical 
protocol to that used for nanoshells.  For each nanorod-dsDNA sample we compared the 
thermal treatment DNA release curve to the laser treatment DNA release curve with all of the 
experimental conditions for the nanorod-dsDNA samples identical to the nanoshell-dsDNA 
experiments (see methods section).  Additionally, we investigated the light-induced release 
of DNA from nanorods by exciting the transverse plasmon resonance of the nanorod with a 
532 nm CW laser.  For nanorods, we fully expected to see a similar trend in the light-induced 
process with respect to our observations for nanoshells, but to our surprise, the nanorods did 
not exhibit light-induced release of DNA. 
The thermal treatment of the nanorod-dsDNA sample results in a ssDNA release 
curve with a melting temperature of ~ 45°C (Figure 4-3B, black squares).  NIR laser 
irradiation (λLASER = 800 nm, 1.3 W/cm
2
), which drives the longitudinal plasmon resonance 
of the nanorod results in a ssDNA release curve (Figure 4-3B, red dots) that looks extremely 
similar to the thermal ssDNA release curve, with no measureable increase in DNA release at 
temperatures significantly below the thermal temperature.  The inset highlights the 
temperature range, 40°C and below, prior to thermal melting where light-induced release 
would be clearly distinguishable if it were observed. The entire heating process for the 
longitudinal laser treatment on the nanorod-DNA sample takes about 6 minutes (Figure 4-3B, 
top axis) which is approximately half the time of the nanoshell sample.  This faster heating in 
the nanorod solution occurs because the nanorods absorb a higher percentage of light than 
they scatter due to their smaller size.  The optical density (total extinction cross section) of 
both the nanoshell-DNA and nanorod-DNA samples were kept constant, so the nanorod 
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solution absorbs a higher percentage of the light resulting in faster heating of the sample.  
The lack of light-induced release below the DNA melting temperature is therefore surprising 
if the process is driven by a nonequilibrium thermal mechanism: however, the thermal 
response observed here is consistent with another recent study of this system.
147
 
Next, we investigated light-induced release of DNA from nanorods when the 
transverse plasmon resonance is excited.  The thermal treatment for this nanorod-DNA 
sample (Figure 4-3C, black squares) results in a dsDNA melting temperature of ~ 50°C.  The 
laser treatment (λLASER = 532nm, 25 W/cm
2
) exciting the transverse plasmon results in a 
DNA release curve that again looks similar to the thermal treatment (Figure 4-3C, green 
dots).  The inset highlights the temperature range, 45°C and below, prior to thermal DNA 
release where light-induced release would be distinguishable, if it were observed.  The 
heating with the 532 nm laser for the transverse excitation of nanorods occurs the fastest (3.5 
minutes), but light-induced release was still not observed.  The faster heating occurs for 
several reasons. At this excitation wavelength, direct absorption of light by water is 
significantly greater than at 800 nm; additionally, the intensity of the incident laser was 
increased from 1.3 to  25 W/cm
2
 to compensate for the smaller absorption cross section of 
the transverse plasmon resonance.  Also, for randomly oriented nanorods in solution under 
polarized light excitation, twice as many will be excited with transverse polarization relative 
to longitudinal polarization since there are twice as many orientations where the transverse 
plasmon would be excited.
146
  If we compare the nanoshell and the nanorod heating 
experiments during the time window prior to DNA melting: for nanoshells there was 
significant DNA release, while for nanorods there was virtually no DNA release. 
58 
 
 
 
 
Figure 4-3. Thermal and Light-Triggered Release of ssDNA from Au nanorods. (A) 
Schematic of ssDNA release.  The thiolated sequence (red) attaches to the Au surface.  
The complementary sequence (blue) is tagged with a fluorescein molecule (green).  
Upon heating (thermal treatment) or illumination with laser light (laser treatment) the 
blue sequence is released and separated from the nanorods by centrifugation.  The 
fluorescence is then measured and normalized by nanorod concentration. (B-C) 
Number of DNA strands released per nanorod as a function of solution temperature for 
thermal treatment (black squares) and laser treatment with either (B) a near-infrared 
laser (λlaser=800 nm) at the longitudinal resonance of the nanorod (red dots) or (C) a 
visible green laser (λlaser=532 nm) at the transverse resonance of the nanorod (green 
dots). The inset shows the expanded view of the temperature range prior to thermal 
melting where light-triggered release is not observed. 
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As is clearly observed, the laser-induced DNA release that is observed on nanoshell 
substrates occurs at a significantly lower solution temperature than DNA melting on the same 
nanoparticle substrate, indicating that dehybridization of DNA occurs faster than 
macroscopic heating of the solution.  There are two plausible mechanisms that may account 
for this behavior:  a nonequilibrium thermal mechanism, or a nonthermal mechanism.  In a 
nonequilibrium thermal process, the irradiated nanoparticle would undergo a very rapid local 
temperature increase at its surface, providing enough local heating to melt the DNA 
molecules prior to increasing the ambient solution temperature.  A nonthermal mechanism 
would involve a process related to the excitation of the nanoparticle surface plasmon, such as 
the transfer of hot electrons from the metal to the adsorbate DNA,
80, 148
 which would increase 
the electrostatic repulsion between DNA strands resulting in DNA dehybridization.    
Following excitation, the nanoparticle plasmon can decay either by radiative damping 
(scattering) or energetic relaxation (absorption via Landau damping), which creates 
nonequilibrium electron-hole pairs.
149
 These “hot” excited electrons undergo rapid electron-
electron scattering and within a few femtoseconds establish a nonequilibrium hot electron 
distribution that can be characterized by an elevated temperature. This hot electron 
distribution then thermalizes with the lattice via electron-phonon coupling on a picosecond 
timescale.  This energy is then dissipated to the surrounding medium via phonon-phonon 
coupling within hundreds of picoseconds, which results in heating of the ambient solution.
66
   
When molecules are adsorbed on the metallic nanoparticle surface, excited “hot” electrons 
can transfer to the adsorbate prior to thermalization.
82-83, 149
 Numerous groups have observed 
photoinduced charge transfer under low intensity CW laser illumination conditions at the 
peak plasmon resonance of metal nanoparticles.
82, 148, 150
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Nonequilibrium Thermal Mechanism. To understand our observations of DNA 
release relative to the energy dissipation and heating occurring in our nanoparticle solutions 
we need to understand these processes in greater detail.  In all experiments reported, the 
interparticle distances are sufficient to eliminate interparticle coupling between the plasmon-
enhanced electric fields, which can affect the local heat generated around a nanoparticle.  For 
the nanoshell-dsDNA and nanorod-dsDNA solutions, the particle density is 1.8x10
10 
nanoshells/mL and 6.14x10
11
 nanorods/mL, which gives an interparticle spacing of 3.8 µm 
and 1.2 µm, respectively.  Each individual nanoparticle can be considered as an independent 
heat source, and plasmon coupling can be neglected.  The localized increase in temperature 
around a single nanoparticle depends upon the absorption cross section, laser intensity, size 
of the nanoparticle, and thermal conductivities of both the metal and surrounding medium. 
67-
69, 151-152
  The temperature increase on the surface of an individual nanoparticle in aqueous 
solution is:
151
  
 
water
abs
βκπR4
Iσ
eq
NPT 
 
(4-1) 
where absσ = absorption cross section (m
2
), I = intensity of the incident light (W/m
2
), 
= radius of a sphere with the same volume as the particle   m43R 31NPeq V
,  = Thermal capacitance coefficient dependent on nanoparticle 
aspect ratio (AR)    ARln0.965871  β 2   and  = 
thermal conductivity of water.  For the thermal capacitance coefficient, the aspect ratio of the 
nanoshell and nanorod is 1 and 3.6, respectively.  For our series of experiments, the 
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absorption cross sections for nanoshells and nanorods used were 
214
NS abs, m10x1σ
 ,
215
NR abs, m10x75.2σ
 ,146 2 W/cm1.3I  , nm75R , NSeq , nm6.11R , NReq , 1βNS  , 
65173.2βNR  , and mKW6.0κwater  .  Based on these parameters, we calculate 
theoretical temperature increases of K10x3.2 4 NST and K10x5.1
4 NRT  at the 
nanoshell and nanorod surfaces, respectively.  These small increases in temperature on the 
surface of the nanoparticles are primarily a result of the low CW optical intensities used in 
these experiments (1.3 W/cm
2
).  To obtain a significant temperature increase on the 
nanoparticle surface, optical intensities would be required to be ~10
4
-10
5
 W/cm
2
, requiring 
pulsed laser sources.
152
  The observed ambient solution heating must therefore be a result of 
accumulative heating, in agreement with similar analyses by Govorov and coworkers.
67-69
  
Nonthermal Mechanism. The very small increases in nanoparticle surface 
temperature estimated for our experimental conditions suggest that a nonthermal mechanism 
may be responsible for light-triggered release.  Since the creation of nonequilibrium hot 
electrons is a direct result of plasmon excitation of the nanoparticle, the greatest number of 
hot electrons will be generated by illumination at the plasmon resonance of the nanoparticle, 
where absorption is the highest.  The probability of charge transfer increases with an 
increasing number of hot electrons.  Because hot electron generation is dependent upon 
absorption, the magnitude of the nanoparticle absorption cross section will affect hot electron 
generation.  For the  [r1, r2] = [60, 76] nm nanoshells and [w, l] = [13, 47] nm nanorods used 
in these studies, the nanoshell to nanorod absorption cross section ratio is approximately four 
 4σσ NR abs,NS abs,  , making it significantly more likely for hot electron-induced charge 
transfer to occur at the surface of a nanoshell.  
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Brus and coworkers have previously demonstrated that enhanced photochemistry can 
occur in areas of intense local fields at metal surfaces. 
149, 153-154
  To evaluate the properties of 
plasmon-resonant local fields on nanoshells and nanorods specific to these studies, the near-
field optical properties of nanoparticles of the dimensions used in our experiments were 
calculated using the Finite-Element Method (FEM), Figure 4-4.  The dielectric function for 
Au determined by Johnson and Christy was used
145
 and the nanoparticles were assumed to be 
embedded in H2O (see methods for simulation details).  For 800 nm laser excitation the 
maximum enhancements calculated for nanoshells ([r1, r2] = [60, 76] nm) and nanorods ([w, 
l] = [13, 47] nm) were 7 V/m, (Figure 4-4A, i) and 38 V/m (Figure 4-4A, ii), respectively.  
While the maximum electromagnetic field enhancement is largest for nanorod longitudinal 
excitation, this large local field is confined only to the tips of the rods and decays rapidly 
with increasing distance from the nanorod surface (Figure 4-4B, Nanorod).  By comparison, 
the weaker local field on the nanoshell surface is distributed over a larger surface area and 
decays more slowly with increasing distance (Figure 4-4B, NS).  Although the field 
enhancement maxima are larger on the nanorod surface, the surface area providing these 
large field enhancements is much smaller on the nanorod (Figure 4-4A, inset). If charge 
transfer correlates with regions of large local field on the nanoparticle surface, fewer DNA 
molecules would be susceptible to charge transfer-induced processes in a nanorod-based than 
in a nanoshell-based complex.  For a single nanorod, assuming a uniform coverage of 
dsDNA on the nanorod surface, approximately 12 dsDNA strands (6 on each end) on 
average, would be located on the ends of the nanorod where the enhancements are the 
highest.  Therefore, although a nonthermal mechanism for DNA release is in principle 
possible on any plasmonic nanoparticle surface, in the complexes fabricated for this series of 
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experiments, the number of DNA molecules released by this mechanism, per nanoparticle, 
should be far greater from the nanoshell-based complex than from the nanorod-based 
complex.  
 
Figure 4-4. Near-field intensity enhancements of nanoshells ([r1, r2] = [60, 76] nm) and 
nanorods ([w, l] = [13, 47] nm) calculated using the Finite-Element Method (FEM).  (A) 
Enhancements for a (i) nanoshell and (ii) nanorod (longitudinal polarization) when 
driven at λ = 800 nm.  Inset of nanorod depicts the size difference between nanoshells 
and nanorods.  (B) Electric field enhancement as a function of distance from the 
nanoparticle surface in the polarization direction for nanoshells (blue) and nanorods 
(red).  (C) Nanorod enhancements when driven at λ = 532 nm for: (i) transverse 
polarization and (ii) longitudinal polarization.  
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If the transverse resonance is excited, then the local field will affect a greater number 
of dsDNA molecules, because the transverse plasmon would excite a greater area of the rod.  
However, the release of ssDNA upon transverse excitation with a 532 nm laser was not 
observed experimentally (Figure 4-3C).  This result can most easily be explained because the 
transverse resonance is highly damped due to interband transitions, attenuating the near field 
for the transverse nanorod plasmon. 
Additionally, in order to attach dsDNA to Au nanorods, an alkanethiol is required 
during the roundtrip phase transfer ligand exchange method.  Although direct attachment of 
dsDNA to nanorods was attempted, it was determined that the roundtrip phase transfer ligand 
exchange method used for these set of experiments gave the most reliable and highest 
dsDNA surface coverage.  The residual alkanethiol molecules on the surface of the nanorod 
could be playing a role in regards to the charge transfer process.  This effect would only be 
noticed in areas of high electric field, where hot electrons are generated; and for nanorods, 
this area of enhanced electric field is much smaller compared to nanoshells.  Further study 
may be needed to investigate the effect the alkanethiol has on light-triggered release. 
Finally, the dsDNA packing density for these nanorod-dsDNA samples (~4.4 
pmol/cm
2
) presented in this article is approximately half that of nanoshells (~11.5 pmol/cm
2
), 
which could potentially affect the light-triggered release process.  However nanorod-dsDNA 
samples with packing densities comparable those on nanoshells (~120 DNA/nanorod, ~13.2 
pmol/cm
2
), still did not exhibit light-triggered release with the 800 nm laser excitation 
(Appendix A, Figure A-2).  Additionally, the fluorescence intensity of the fluorescein-tagged 
DNA was unaffected by laser irradiation (Appendix A, Figure A-3) 
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4.4. Conclusion 
We have examined the process of light-induced DNA release, relative to thermally 
induced DNA melting, on specially functionalized Au nanorod and nanoshell complexes.  A 
clear distinction between light-induced DNA release, occurring at temperatures well below 
thermal release, and thermally-induced DNA release was observed on nanoshell-based 
complexes.  For nanorod-based complexes treated under the same irradiation conditions only 
thermally-induced release of DNA was observed. In our experimental regime, where 
irradiation of the nanocomplexes is performed using low-intensity CW laser sources, the 
nanoparticle surface temperature increases appear minimal, and a nonequilibrium thermal 
mechanism involving high local temperatures at the nanoparticle surface appears unlikely for 
light-induced release.  Instead, it appears quite feasible that the observed light-induced 
release may be explained by a nonthermal model, where hot electrons produced by plasmon 
decay are transferred to the adsorbate host-cargo system, facilitating dehybridization well 
below the DNA melting temperature.  While both complexes should be responsive to such a 
release mechanism, differences in absorption cross sections and DNA densities on the 
nanoparticle surfaces render this effect observable only on nanoshell based complexes, for 
the present set of experimental conditions.  Further examinations of this process should 
enable the development of light-induced release based vectors for a wide range of 
nanoparticle morphologies, and the design of more efficient plasmonic nanoparticle-based 
delivery vectors. 
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Chapter 5 
 
Visualizing light-triggered release of 
molecules inside living cells 
This work was done in collaboration with Oara Neumann (equal contributor), Aoune 
Barhoumi, and Naomi. J Halas at Rice University.  Lin Ji from The University of Texas MD 
Anderson Cancer Center allowed me to use the cell culture facility in his lab.  
5.1.  Introduction 
Strategies for the directed release of controlled quantities of molecules inside living 
cells are in high demand for drug delivery,
155
 gene therapy,
156-157
 and tissue engineering.
158-
159
  The release mechanisms of most delivery vectors depend on processes such as diffusion, 
dissolution, chemical and enzymatic reactions, or changes in various environmental factors 
such as temperature, pH, solvent, and ionic concentrations.
156, 160-163
  For example, 
transfection reagents such as polyethylenimine act as a proton sponges following 
endocytosis, absorbing protons in the low-pH environment of the endosome, causing it to 
swell and eventually rupture, facilitating gene delivery.
164
  This type of environmental 
control of molecular release varies with cellular location and cell type, and can result in 
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unpredictable release.  A physical release mechanism that does not rely on the specific 
chemical properties of the cellular environment would be highly useful and more easily 
generalizable to various cell types.
165
  Light-induced release is a particularly attractive 
option: the high spatial and temporal control that lasers provide would be highly useful for 
initiating and following intracellular processes dynamically, at the single cell level.
31, 106, 166-
170
   
Plasmonic nanoparticles, metal-based nanostructures supporting collective electronic 
oscillations, are highly promising potential candidates for facilitating controlled light-
triggered release, due to their large optical cross sections, their geometrically-tunable optical 
resonances
171-172
 and their strong photothermal response.
173-174
  Because of their large cross 
sections and extremely low quantum yield, metallic nanoparticles convert optical energy to 
thermal energy with high efficiency upon resonant optical illumination.
69, 175
  Resonant 
optical illumination of the nanoparticle triggers the controlled dehybridization and release of 
DNA molecules adsorbed onto the nanoparticle surface.
168, 170
  Au nanoparticles are also 
biocompatible, easy to fabricate, and can be functionalized with a wide variety of host-carrier 
molecules capable of noncovalent accommodation of guest molecules.
160, 170
 
Au nanoshells, metallodielectric nanoparticles comprised of a spherical dielectric core 
covered by a thin Au shell, have been successfully employed in a range of biomedical 
applications
176-178
 including photothermal cancer therapy.
174, 179-180
  The plasmon resonance 
wavelength of a nanoshell can be varied by changing the core size and shell thickness.
172, 181
  
This tunability is particularly important for biomedical applications because the nanoshell 
can easily be designed to have a large absorption efficiency in the near infrared (NIR) water 
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window (690-900 nm), where blood and tissue are maximally transparent and light can 
penetrate tissue to depths of several inches.
182
  
Recently we demonstrated light-induced dehybridization of double-stranded DNA 
(dsDNA) attached to Au nanoshells.
170
  Nanoshells of dimensions [r1, r2] = [63, 78] nm with 
the plasmon resonance wavelength at 800 nm were coated with dsDNA, where one strand of 
the DNA had a thiol moiety on its 5’ end, facilitating covalent attachment to the nanoshell 
surface by a Au-thiol bond. The complement DNA sequence was nonthiolated, and therefore 
bound only to its complementary DNA sequence and not to the nanoparticle surface. Upon 
illumination with NIR light at the nanoshell plasmon resonance wavelength, the dsDNA was 
dehybridized, releasing the antisense sequence. This process is highly efficient, resulting in 
the dehybridization and release of nominally 50% of the DNA from the complexes upon 
illumination, with no apparent temperature increase in the solution ambient. DNA antisense 
therapy has been explored extensively as a class of gene therapy and has highly promising 
potential to provide safe and effective treatments for a multitude of diseases and genetic 
disorders.
183
  
Here we show that, in addition to light-controlled release of DNA, the nanoshell-
dsDNA complex serves as an effective host and light-triggered release vector for other types 
of molecules.  Many types of guest molecules can associate with dsDNA, either by 
intercalating between adjacent base pairs or by binding in either the major or minor groove of 
the DNA double helix.
184
  The driving forces for association can include π-stacking, 
hydrogen bonding, van der Waals forces, hydrophobic and polar interactions, and 
electrostatic attractions; therefore, dsDNA can host a large variety of guest molecules via 
noncovalent bonds.
184-185
 DAPI (4',6-diamidino-2-phenylindole), a water soluble blue 
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fluorescent dye that binds reversibly with dsDNA (Figure 5-1) is the molecule we chose to 
deliver, to demonstrate and clearly visualize the light-induced intracellular release.  DAPI 
was chosen because of its bright  fluorescent properties, stability and negligible toxicity.
186
 
DAPI binds preferentially to the minor grooves of dsDNA: its association with DNA causes a 
large increase in its quantum yield.
186-190
 The selectivity of DAPI to dsDNA makes it a 
frequently used, standard stain for cell nuclei in fluorescence microscopy.
189-190
   
 
Figure 5-1. Fluorescence emission of DAPI as a function of temperature (heat rate is of 
10C/min) showing reversible binding of DAPI (i) from dsDNA in solution and (ii) from 
nanoshell-dsDNA-DAPI complexes.  As the DAPI is released, the fluorescence emission 
intensity decreases. 
5.2. Experimental Methods 
Reduction of thiolated ssDNA.   The oligonucleotides used in this study are: 26-bp 
DNA oligo: 5’-GAT ATC CTA TAC GGA ATT CGA ATT CG-3’, 50bp DNA oligo: 5’-
GAC TGC GAC CAA CCT AGC CTG CTA TGA TGT ACG GTC AAC CTG ATT GCC 
GC-3’, and the complementary 26bp and 50bp ssDNA sequences for both strands.  DNA was 
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purchased from Integrated DNA Technologies (IDT) Inc. The thiolated ssDNA [26 or 50 bp]  
was incubated with 100 mM of DTT (reducing agent) in 100 mM sodium mono-phosphate 
buffer at pH=7.5. The mixture was incubated at room temperature for 1 hour to allow for 
complete reduction of the disulfide bonds. The solution was then filtered through a NAP-5 
column to remove the excess DTT.  Elution of the column with water was performed to 
collect the purified ssDNA in H2O. The concentration of the ssDNA stock solution was 
determined by measuring its absorbance at 260 nm, using a UV-Vis-NIR spectrophotometer 
(Cary 5000, Varian Inc.).   
Nanoshells preparation and DNA Functionalization.  Silica core-Au nanoshells 
were fabricated using a method previously described.
191-192
 Au-silica nanoshells were 
fabricated with core and shell dimensions of [r1, r2] = [63, 78] nm, corresponding to a 
nanoshell plasmon resonance at 800 nm in aqueous solution, which is the wavelength of the 
excitation laser used in the photothermal experiments. dsDNA was hybridized by mixing two 
complementary ssDNA sequences at a 1:1 molar ratio in DNA hybridization buffer (Tris 
EDTA (TE)/50mM NaCl, pH=7.5), heating the solution to 95
0
C for 10 min in a large water 
bath and then cooling slowly to room temperature. dsDNA was attached to nanoshells via 
overnight incubation and continuous shaking. To remove the excess dsDNA the solution was 
washed three times by centrifugation and resuspension in TE buffer. 
DAPI stained DNA-functionalized nanoshells.  DAPI (Sigma) was used without 
further purification. The concentration of the DAPI stock solution was determined 
spectrophotometrically using the molar absorption coefficient (ε342nm=23,000 M
-1
cm
-1
 for 
DAPI in water). The stock DAPI solution was kept stored at -20
0
C. After purification the 
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NS-dsDNA complexes were incubated overnight with DAPI solution and then washed three 
times by centrifugation and resuspension in TE buffer to remove the excess DAPI. 
Cell Preparation and Nanocomplex incubation.  The H1299 lung cancer cells are 
cultured in media (Gibco) supplemented with 5% heat-inactivated fetal bovine serum, 1% 
antibiotics and maintained in a 37°C incubator with 5% CO2 air. Cells were initially seeded 
in 6-well plates at a density of 400,000 cells/well 24 hours prior to incubation with nanoshell-
dsDNA-DAPI complexes.  The nanoshells were added to the serum containing media in a 
NS:Cell ratio of 10,000:1.  After 1 hours of incubation with nanoshell-dsDNA-DAPI 
complexes, the media was aspirated off.  Cells were washed two times with PBS.  Cells were 
detached from the plate with trypsin and the cells were finally suspended in additional media.   
Laser Treatment.  Half of this cell/media suspension underwent laser treatment (5 
minute illumination at 80o nm with continuous wave laser, 1W/cm2).  The other half did not 
receive a laser treatment. This laser power and time is chosen from previous DNA 
dehybridization studies. After laser treatment, both samples (laser and no laser) were allowed 
to incubate for 1 hour to allow released DAPI molecules to diffuse to the nucleus.   
Isolation of Nuclei and Flow Cytometry.  Nuclei were isolated using Nuclei 
Isolation Kit: Nuclei EZ Prep (Sigma Aldrich, NUC101-1KT).  Briefly, the cells were 
collected via centrifugation (500xg/4°C/5min).  Washed once with PBS.  Resuspended and 
centrifuged twice in Nuclei EZ Prep lysis buffer.  Final suspension was in 250 uL of PBS.  
Flow cytometry was performed on BD influx.  The excitation laser was a 355nm solid state 
UV laser.  Emission was collected at 460nm.  Data was analyzed by FlowJo and the 
histograms were normalized by % of max.   
72 
 
 
 
Statistical Analysis.  For statistical analysis, the SEM (standard error of the mean) 
was calculated by dividing the standard deviation by the sample size.  Sample size for Figure 
5-6a: 19,100.  Sample size for Figure 5-6b: 47,800.  Because of the large sample sizes, the 
data was treated as being normally distributed, which is preferred over using a nonparametric 
statistic test.  An unpaired t-test was performed to determine the significance at a 95% 
confidence interval.  The p-value reported is a two-tailed p-value.  A p-value less than 0.05 is 
determined to be statistically significant.   
Cytoviva Microscope.  The Cytoviva microscope is a dark-field/epifluorescence 
microscope.  Excitation and emission filters on the dual mode fluorescence microscope are 
used to choose the right wavelengths of light for fluorophore excitation and emission 
collection.  All images are taken with a 40x objective.  The white light source is an Expo 
Cytoviva X-cite series 120 light source, mounted on an Olympus BX41 microscope.  The 
camera is a Dage Technologies Exponent CCD camera. 
Cytoviva Sample Preparation.  After laser treatment, cells were plated and grown 
on chamber slides as previously described.  Chamber slides are used so that the walls of the 
slide can be removed and imaging can be done on the slide.  After 12 hours of incubation, 
cells were washed three times with 1x PBS.  A fixing solution (4% paraformaldehyde) was 
added to the chamber slide and allowed to incubate for 15 minutes at room temperature.  The 
fixing solution was aspirated off and the cells were washed three times in 1x PBS. A staining 
solution of Alexa Fluor 488 (5.0 μg/mL in PBS) was added to the chamber slide and allowed 
to incubate for 10 minutes at room temperature.  Staining solution was aspirated off and the 
cells were washed twice with 1x PBS.   The cells were then mounted with anti-fade 
fluorescence mounting medium and glass coverslip. 
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5.3.  Results and Discussion 
A schematic of the light-triggered molecular release is shown in Figure 5-2. Initially, 
nanoshell-dsDNA complexes were loaded with DAPI by incubation of DAPI with the 
nanoshell-dsDNA complexes.  Next, the nanoshell-dsDNA-DAPI complexes were incubated 
with H1299 lung cancer cells, where intracellular uptake was verified using both dark-field 
and bright-field microscopy.  Upon illumination with an 800 nm CW laser, corresponding to 
the peak resonant wavelength of the nanoshell complexes (Figure 5-3), the DAPI molecules 
were released from the nanoshell complexes. Subsequent to release, the DAPI diffused 
through the cytoplasm and into the cell nucleus, where it preferentially bound and stained the 
nuclear DNA. To the best of our knowledge, this is the first light-controlled delivery system 
that can be tailored to release quantifiable amounts of nonbiological molecules, within living 
cells by remote means, on demand. 
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Figure 5-2 Light-induced DAPI release. (a) Schematic diagram of the light-induced 
DAPI release and diffusion inside the cell. (b) Fluorescence emission of (i) DAPI only, 
(ii) DAPI with ssDNA, and (iii) DAPI with dsDNA.   
 
The DAPI fluorescence emission intensity drastically increases as a result of DAPI 
molecules binding to DNA (Figure 5-2b).  As an isolated molecule, DAPI  has a low 
quantum yield (Figure 5-2b, i), 
187
  however, when DAPI is attached to single stranded DNA 
(ssDNA) (Figure 5-2b, ii), a weak electrostatic attraction binds the cationic DAPI molecules 
to the negatively charged phosphate backbone of the DNA, resulting in a slight increase in its 
fluorescence intensity. 
187
  When the DAPI molecules bind to the minor grooves of the 
dsDNA (Figure 5-2b, iii),
187, 190
 the increased rigidity and stabilization significantly increases 
its quantum yield.
186
  DAPI binding to the dsDNA also displaces H2O molecules initially 
solvating the DNA oligomers, significantly reducing intermolecular proton transfer between 
H2O and DAPI, resulting in an additional increase of DAPI fluorescence intensity.
187-188, 193
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Figure 5-3. (a) Extinction spectra of [r1, r2] = [63, 78] nm NSs in water.  (b) SEM image 
of NSs on silicon substrate. 
 
The specific base-pair composition of the dsDNA plays an important role in 
determining the number of DAPI molecules that will bind to the dsDNA.
194
  Previous studies 
have shown that DAPI preferentially binds to regions rich with adenine (A) and thymine (T) 
nucleotide bases because DAPI forms hydrogen bonds with A-T bases pairs.
190
  The DAPI 
molecule is 14-15 Å long, corresponding to an overlap of three base pairs.
187-189, 194
  In our 
experiments, since it is desirable to bind as many DAPI molecules as possible to improve the 
staining of the nucleus after light-induced release, we designed a 26-base pair sequence with 
multiple A-T-rich regions with segments of three or more consecutive A-T base pairs to 
specifically enhance DAPI loading (Figure 5-4).   
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Figure 5-4. Fluorescence spectra of (i) DAPI alone, (ii) DAPI with ssDNA, and (iii) 
DAPI with dsDNA solutions; (A) 26 bp DNA and (B) 50 bp DNA oligonucleotide, 
demonstrating the affinity for AT-rich binding sites. The DNA oligonucleotides used in 
this study are: 26-bp DNA oligo: 5’-GAT ATC CTA TAC GGA ATT CGA ATT CG-3’ 
and 50bp DNA oligo: 5’-GAC TGC GAC CAA CCT AGC CTG CTA TGA TGT ACG 
GTC AAC CTG ATT GCC GC-3’ 
 
To use this light-triggerable complex for molecular release in live cells, the complex 
must first be effectively taken up by the cells of interest. To facilitate cell uptake, the 
nanoshell-dsDNA-DAPI complexes were incubated with H1299 lung cancer cells in serum 
containing cell culture medium for 1 hour.  After incubation, the cells were fixed and 
internalization of the nanoshell-dsDNA-DAPI complexes was imaged using both dark field 
(Figure 5-5a-b) and bright field (Figure 5-5c) microscopy.  Nanoshells in this size range both 
absorb and scatter light: their strong scattering cross section enables them to be easily 
visualized by optical microscopy.  In Figure 5-5a, a H1299 cell with its cell membrane 
marked by the green fluorescence dye Alexa Fluor 488 WGA (wheat germ agglutinin) is 
shown. Internalized nanoshells are easily seen as diffraction-limited bright spots in this 
image. As a control, cells not incubated with the nanoshell-dsDNA-DAPI complexes showed 
no observable bright spots when imaged in the same manner (Figure 5-5B).  
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Figure 5-5. Nanoshell-dsDNA-DAPI Cell uptake. Dark field/epifluorescence images of 
(a) H1299 lung cancer cells incubated with nanoshell-dsDNA-DAPI complexes, (b) 
nonincubated cells (control). (c) Bright field image of middle slice of H1299 lung cancer 
cells incubated with nanoshell-dsDNA-DAPI complex.   
 
Because the dark-field images are two-dimensional, these images alone do not give 
clear evidence whether the nanoshell complexes have been endocytosed, or are merely 
adsorbed onto the outer membrane of the cell. Bright-field imaging was used to further 
investigate cellular uptake. Obtaining images at varying depths of field within an individual 
cell allows us to clearly visualize in three dimensions the nanoshell distribution within the 
cell.  Figure 5-5c is a slice from the middle of the cell showing clear diffraction-limited dark 
spots corresponding to nanoshell complexes, verifying that the nanoparticles are internalized 
within the cell.  Internalization of nanoshells is in agreement with observations by 
Ochsenkühn et al, who used TEM sections of NIH-3T3 fibroblast cells to confirm nanoshell 
uptake.
195
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At first thought, it is surprising that the nanoshell-dsDNA-DAPI complex is 
internalized into cells because the negatively-charged phosphate backbone on the DNA 
should experience electrostatic repulsions with the negatively-charged cell membrane.
196
  
However, previous studies by Chithrani et al and Giljohann et al suggest that Au 
nanoparticles functionalized both with and without DNA adsorb extracellular serum proteins 
from the cell culture media.
196-197
  The adsorbed extracellular proteins then interact with the 
cell membrane and facilitate cellular uptake in an adsorptive endocytosis pathway. 
Conversely, recent studies by Ochsenkühn et al show that nanoshell uptake increases in the 
absence of extracellular proteins, suggesting the possibility of a passive, nonendocytotic 
uptake mechanism.
195
  While in our studies nanoshell complex uptake is clearly visualizable 
in H1299 cells, the precise uptake mechanism is not clearly identifiable, and is likely to 
depend on a variety of factors including cell type, functionalization of the nanoparticle, and 
incubation conditions.   
To investigate intracellular light-induced molecular release, the H1299 cells 
incubated with nanoshell-dsDNA-DAPI complexes were illuminated with a NIR CW laser (1 
W/cm
2
, 800 nm) for 5 minutes.  This irradiation time and laser power level were determined 
from previous experiments,
170
 which demonstrated after 5 minutes of laser irradiation no 
additional dehybridization of the DNA occurred.  This laser power and time allow the DAPI 
to be released while minimizing laser exposure to the H1299 cells.  After laser irradiation, 
samples were placed in an incubator for one hour to allow time for released DAPI molecules 
to diffuse to the nucleus.  Next, the nuclei of the cells were isolated by lysing the cell 
membrane and the DAPI fluorescence intensity was quantified by flow cytometry.  Nuclei 
isolation is necessary to ensure that flow cytometry only measures fluorescence from DAPI 
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molecules bound to genomic DNA in the nucleus and does not measure fluorescence from 
DAPI molecules in the cytoplasm. 
Evidence of DAPI release is shown by the normalized flow cytometry histograms of 
DAPI fluorescence intensity versus number of nuclei from H1299 cells incubated with 
nanoshell-dsDNA-DAPI before and after laser treatment (Figure 5-6).  After laser treatment, 
the fluorescence intensity of the nuclei increased, demonstrating that DAPI molecules were 
released from the nanoshells, diffused through the cytoplasm and into the cell nuclei, binding 
with the genomic DNA.  Prior to laser irradiation, some DAPI fluorescence is observed 
within the cells (Figure 5-6c, left) and measured by flow cytometry (Figure 5-6a-b, before 
laser).  This DAPI fluorescence signal originates from both excess DAPI molecules present 
in the sample and DAPI molecules which were non-controllably released from the complexes 
during the incubation and prior to laser irradiation. 
The bar graph depicts the mean DAPI fluorescence intensity ± SEM (standard error 
of the mean) increase from before laser (59.7±0.21) to after laser (79.8±0.33) (Figure 5-6a).  
A ~33% increase in fluorescence intensity.  An unpaired t-test of the two means was 
performed at a 95% confidence level, which resulted in a two-tailed p value of p < 0.0001, 
which is statistically significant.  This observed increase in DAPI fluorescence after laser 
treatment (~33%) demonstrates that the nanoshell-dsDNA complex effectively released its 
guest molecules from the dsDNA host carriers inside the cells.  Epifluorescence images of 
H1299 cells incubated with nanoshell-dsDNA-DAPI before (Figure 5-6c, left) and after 
(Figure 5-6c, right) laser treatment visually show the increase in DAPI fluorescence intensity.  
The cell membrane is marked by the green dye, Alexa-Fluor 488 wheat germ agglutinin. 
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The plasmon resonant illumination of the nanoshells is crucial for DAPI release into 
the cells.  To test this hypothesis, a control experiment consisting of H1299 cells incubated 
with DAPI only (no nanoshells) was conducted (Figure 5-6b). The cells were irradiated with 
the NIR laser under conditions identical to the previous experiment. The mean DAPI 
fluorescence intensity ± SEM did not significantly increase after laser irradiation (237±0.86 
to 239 ± 0.95, p = 0.1188), indicating that DAPI release does not occur without the presence 
of the nanoshell-dsDNA complex.  It is important to note that the mean fluorescence 
intensity is higher for the control (Figure 5-6b) compared to the nanoshell-dsDNA-DAPI 
sample (Figure 5-6a) due to multiple washings of the nanoshell-dsDNA-DAPI sample. 
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Figure 5-6 Light-induced DAPI release. (a-b) Flow cytometry histograms of DAPI 
Fluorescence (Ex: 355nm/Em: 460 nm) versus number of isolated nuclei from H1299 
cells incubated with a) nanoshell-dsDNA-DAPI and b) DAPI (control). Negative control 
(gray), treated cells without laser irradiation (blue) and treated cells with laser 
irradiation (red).  Bar graphs display the mean DAPI fluorescence intensity ± SEM 
before and after laser irradiation. (c) Epifluorescence images of H1299 cells incubated 
with nanoshell-dsDNA-DAPI (left) before and (right) after laser treatment.  The cell 
membrane is marked by the green dye, Alexa-Fluor 488. 
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The shape of the flow cytometry histograms for both before laser and after laser are 
consistent with nuclei stained with DAPI.
198-199
  DAPI is routinely used to study the cell 
cycle because it binds to DNA stoichiometrically.  Looking at the before laser histogram in 
Figure 5-6a as an example, the tallest peak (~40) originates from nuclei with two sets of 
chromosomes.  This peak is the tallest because in a typical cell cycle, a cell spends the 
longest portion of time with two sets of chromosomes; therefore, the probability of a cell 
having two sets of chromosomes is the highest.  The second, smaller peak (~80), double the 
fluorescence intensity of the tallest peak, indicates nuclei which have exactly double the 
amount of DNA, four sets of chromosomes, and are ready to enter mitosis and divide.  The 
nuclei with fluorescence intensities in between these two peaks indicate cells which are 
currently synthesizing DNA prior to mitosis.  The negative control histogram (gray) has a 
single peak because in the absence of DAPI every nuclei essentially fluoresces identically 
resulting in a signal which is attributed to autofluorescence (background).    
To ensure that this method for light-triggered intracellular molecular release would be 
useful for biomedical applications, such as drug delivery, a cytotoxicity assay was performed 
to investigate both the effects of nanoshells and laser irradiation on cell viability.  Propidium 
iodide (PI) was chosen as a marker to distinguish viable from non-viable cells, because it is a 
membrane-impermeable dye which is excluded from viable healthy cells.
200
  When a cell 
membrane is damaged, PI enters the cell, stains the dsDNA in the nuclei and emits red 
fluorescence; however, undamaged cells will not fluoresce.  Flow cytometry was used to 
observe changes in PI fluorescence intensity for a large sample size of 30,000 cells.  The 
negative control (Figure 5-7a) consisted of cells which were not incubated with nanoshell-
dsDNA-DAPI and did not undergo laser treatment.  The fluorescence observed in Figure 
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5-7a is attributed to autofluorescence and PI staining caused by apoptotic and necrotic cells 
already present in the experiment, with damaged membranes. The nanoshell-dsDNA-DAPI 
complexes were then incubated with H1299 cells for 12 hours.  Following incubation, the 
cells were divided into two samples: cells not treated with the laser (Figure 5-7b) and cells 
treated with the laser for 10 minutes (Figure 5-7c). Figure 5-7b shows no significant increase 
in PI fluorescence intensity, demonstrating that nanoshell-dsDNA-DAPI complexes are not 
cytotoxic under the experimental conditions of the study. 
 
Figure 5-7 Flow cytometry cytotoxicity assay.  All plots are side-scattered light (SS) 
versus Propidium Iodide (PI) intensity. (a) Negative control: H1299 cells not incubated 
with nanoshell-dsDNA-DAPI and no laser treatment. Cells incubated with nanoshell-
dsDNA-DAPI for 12 hours: (b) without laser treatment and (c) with laser treatment. (d) 
Positive Control: Cells were treated with 0.1%Citrate/0.1%Triton, which permeates the 
cell membrane, allowing PI to stain the dsDNA in the nucleus.   
 
More interestingly, cells incubated with nanoshell-dsDNA-DAPI complexes and 
irradiated with the laser for 10 minutes, Figure 5-7c, also show no significant increase in PI 
fluorescence intensity. This demonstrates that the light-triggered release procedure did not 
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adversely affect the cells.  Considering nanoshells are well-known for their use in 
photothermal therapy, this result may be surprising; however, the illumination conditions for 
this experiment (1W/cm2, 5 minutes) were significantly below those used for photothermal 
induction of cell death in cell culture (4W/cm2, 4-6 minutes).
174
  Figure 5-7d represents a 
positive control sample of cells treated with 0.1% Citrate/0.1% Triton solution, which 
permeates the cell membrane, allowing PI to enter the cell and stain the nucleus, resulting in 
a large increase in PI fluorescence intensity.   
5.4.  Conclusion 
In conclusion, nanoshells functionalized with dsDNA were successfully used to 
transport DAPI molecules into living cells. Successful uptake of nanoshells into H1299 cells 
was achieved.  DAPI molecules, initially bound to the dsDNA on the NS surface, are 
released due to the illumination of the nanoshell-dsDNA-DAPI complex with the appropriate 
NIR light.  DAPI molecules initially released in the cell cytoplasm diffuse into the cell 
nucleus and bind to the genomic DNA of the cell. The staining of the cell nucleus with the 
released DAPI was quantified using flow cytometry.  A cytotoxicity assay demonstrated that 
nanoshell uptake is nontoxic and that laser irradiation of nanoshell-laden cells under the 
conditions where DAPI release occurs does not induce cell death.  
This nanoshell-dsDNA system could be extended to a multitude of other guest 
molecules that associate with the host dsDNA carrier including small organic 
fluorophores,
185
 steroid hormones,
201
 and therapeutic molecules.
184-185, 201
  For example, the 
quest to find dsDNA intercalators that inhibit the uncontrollable replication of tumor cells 
comprises an entire field of cancer research.  Currently, there are more than 130 FDA 
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approved anti-cancer drugs that specifically target DNA.
202
 For in vivo clinical applications, 
however, before the DNA intercalator can reach the genomic DNA, it must overcome several 
hurdles, such as metabolic pathways and cytoplasmic and nuclear membranes. As a result,  
the failure of DNA therapies to offer successful clinical treatments is primarily due a lack of 
viable delivery methods rather than effectiveness of the DNA intercalator to treat cancer.
184
 
This nanoshell-dsDNA delivery vector preserves the guest molecule by minimizing non-
desired interactions with other molecules and it provides light-triggered release with 
controllable delivery. 
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Chapter 6 
 
Gene silencing by Au-nanoshell-mediated 
delivery and laser-triggered release of 
antisense oligonucleotide and siRNA 
This work was done in collaboration with Aoune Barhoumi
 
and Naomi J. Halas from 
Rice University and 
 
Qing Liu, Jack A. Roth, and Lin Ji from The University of Texas MD 
Anderson Cancer Center.  
6.1. Introduction 
RNAi- the use of  short-interfering RNA (siRNA) or antisense DNA oligonucleotides 
to silence or interrupt the activity of specific genes and downregulate expression of their 
encoded proteins- has been proved very useful in dissecting genetic function.
22
  This 
approach holds considerable promise for the development of a new class of molecular 
therapeutic drugs that interferes with disease-causing or -promoting genes, particularly those 
that encode so-called 'non-druggable' targets not amenable to conventional therapeutics.
203
 
However, the main obstacle to achieving gene silencing in vivo by RNAi technologies is 
delivery of therapeutic siRNAs or antisense oligonucleotides, currently becoming a major 
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topic in cancer therapy.  This goal faces many challenges, such as the direction of specific 
gene targets to the appropriate tissue and cell types at safe and effective dosages, and 
maintenance of oligonucleotide stability in circulation.  Strategies for enhancement of 
cellular uptake and methods for monitoring distribution and therapeutic efficacy are also 
needed.
23-24, 34, 203
 Overcoming these obstacles requires new delivery vehicles and targeting 
approaches. Lipid and polymer-based vehicles for administration of siRNAs have been 
developed and tested for delivery to lung, liver and other local tumors in animal models, 
including non-human primate.
24, 203-204
  These RNA or DNA oligonucleotide delivery carriers 
present a variety of potential problems to the patient - toxicity, immune and inflammatory 
responses, and gene control and targeting issues.
23-24, 34, 203-205
 Realizing the full potential of 
RNAi-based molecular therapeutics requires new strategies
32, 106, 108, 206-213
 to substantially 
improve delivery efficiency, toxicity profiles, monitoring techniques, and pharmacological 
and therapeutic efficacy.  
Gold nanoparticles show potential to offer 'on-demand' release in response to optical 
laser excitation due to their plasmon resonance, the collective oscillation of the electrons. 
57, 
105, 143
  Recently, two strategies for light-triggered release have been investigated.  One 
strategy consists of covalently attaching the gene therapeutic to the gold surface. Upon 
femtosecond laser pulses, the nanoparticles either break apart or reshape into small gold 
nanoparticles, which breaks the covalent bond and releases the gene therapeutic.
31, 104-106, 108
  
The second strategy consists of covalently attaching a 'carrier' molecule to the gold surface 
and then loading the 'cargo' gene therapeutic molecule onto the 'carrier' molecule, typically 
by weaker non-covalent bonds.  Upon laser illumination, the nanoparticle absorbs energy, 
which weakens the attraction between the carrier and cargo molecules and releases the 
88 
 
 
 
therapeutic entity.
64, 122, 141-142
  While both strategies show promise, the second strategy may 
be advantageous due to the relatively low laser power densities and short irradiation times 
required to release the therapeutic cargo.   
Gold (Au) nanoshells (NSs) composed of a spherical silica core coated with a thin Au 
shell, show potential to offer ‘on-demand’ release in response to optical excitation.  The 
plasmon resonance of Au nanoshells can be tuned from the visible region into the near 
infrared (NIR) by changing the core size and the thickness of the gold shell.
35
  The NIR 
resonance of NSs enables biomedical applications because the nanoshell can be easily 
fabricated to maximally absorb in the NIR “water window”, where bodily tissue is maximally 
transparent.
39
  Au nanoshells have been used extensively in biomedical applications 
including photothermal cancer therapy.
14-15, 78, 214-215
 Additionally, Au possesses a very well-
established Au-thiol bond chemistry that allows easy functionalization of the nanoshell 
surface with a wide variety of ligands and targeting moieties.
212, 216
   
Recently we demonstrated resonant light-induced release of single-stranded DNA 
(ssDNA) from Au nanoshells.
143, 217-218
 A monolayer of double-stranded DNA (dsDNA) was 
attached to the nanoshell surface via a thiol modification on the 5’ end of a complementary, 
carrier sequence, while a therapeutically antisense sequence to be released was hybridized to 
its carrier complement via Watson-Crick base-pairing.  Continuous wave laser radiation at 
800 nm released the non-thiolated DNA strand from the nanoshell surface.  In this previous 
work, the thiolated DNA sequence is the ‘carrier’ molecule that holds the therapeutic ssDNA 
‘cargo’.  This rudimentary light-triggered delivery system is limited to the release of single 
stranded oligonucleotides. However, its demonstration suggests that noncovalent binding 
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may be used to create a more general ‘carrier’ platform capable of delivering a range of 
different types of oligonucleotide therapies upon NIR irradiation. 
Cationic poly(L)lysine peptides are a promising oligonucleotide carrier.  
Poly(L)lysine has been used extensively as a transfection reagent for gene therapeutics.
219-221
  
Due to the fact that it is positively charged at physiological pH, poly(L)lysine associates 
electrostatically with the negatively charged phosphate backbone of antisense DNA or 
siRNA oligonucleotides.  In addition, the poly(L)lysine can protect the synthetic 
oligonucleotide-based molecular therapeutics from enzymatic degradation by nucleases 
during transport and can increase cellular uptake.
220, 222
 
In this study we developed an NS-based antisense RNAi oligonucleotide delivery 
system.  This nanotherapeutic delivery vector consists of an Au nanoshell  functionalized 
with a cationic poly(L)lysine (PLL) peptide (Cysteine(C)-Tyrosine(Y)-Serine(S)-
Lysine(K)50,) carrier arm for electrostatic capture of intact, negatively-charged therapeutic 
RNAi oligonucleotides.  The thiol side chain on the cysteine amino acid attaches to the gold 
surface, the tyrosine and the serine amino acid serve as spacer and the fifty lysine amino 
acids result in a net positive charge.  To demonstrate the general utility of this delivery 
system, two types of RNAi  ‘cargoes’,  single-stranded antisense DNA oligonucleotides 
(ssDNA) and  double-stranded  siRNA  are alternatively loaded onto the nanoshell-
poly(L)lysine (NS-PLL) vector. Laser irradiation of the NS-PLL delivery vector controllably 
releases the therapeutic oligonucleotides at a controlled time point (Figure 6-1).   We 
investigated the release profile of the ssDNA and quantified the number of ssDNA molecules 
released by both thermal and laser-induced treatment in solution and in living cells in vitro.  
Fluorescently-tagged ssDNA was used to investigate intracellular light-triggered release and 
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endosome rupture.  The NS-PLL vector was also used to deliver either the GFP gene-specific 
antisense DNA oligonucleotide (AON-GFP), or siRNA (siGFP), to evaluate cellular uptake 
and gene silencing potential of this approach in GFP-expressing H1299 lung cancer cells in 
vitro.  
 
 
 
Figure 6-1.  Au-Nanoshell Polylysine (NS-PLL)-based therapeutic RNAi oligonucleotide 
delivery system. The negatively charged phosphate backbone of the siRNA/ssDNA (red) 
is electrostatically attached to the cationic peptide (blue), which consists of one cysteine, 
one tyroosine, one serine, and fifty lysines amino acids.  Upon laser irradiation, the 
siRNA/ssDNA is released.  
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6.2. Results and Discussion: 
Nanoshell synthesis and polylysine functionalization.  
Au nanoshells were synthesized according to a previously published method.
35
 The 
dimensions of the silica core and the Au shell ([r1, r2] = [60, 82] nm) were designed so that 
the peak plasmon resonance in an aqueous suspension occurred at 800 nm, corresponding to 
the laser excitation wavelength used in this experiment.  The PLL peptide (Cysteine (C)-
Tyrosine(Y)-Serine(S)-Lysine(K)50) was custom synthesized (Biomatik USA, LLC) The 
peptide was received as a lyophilized powder and resuspended in Milli-Q water.  An excess 
of the PLL peptide (see methods section) was added to a solution of nanoshells.  This 
solution was allowed to incubate for 24 hours on a rocker at room temperature. The excess 
PLL was removed by centrifugation and resuspended in Milli-Q water.  ζ-potential 
measurements confirmed PLL attachment (Table 6-3).   
Thermal and Light-triggered Release of ssDNA   
Light-triggered release of antisense DNA oligonucleotides (ssDNA) was investigated 
using three types of fluorescently tagged ssDNAs  (Error! Reference source not found.): i) 
n 18-base sequence that was chemically unmodified (short ssDNA), ii) an 18-base ssDNA 
with sequence identical to the first except chemically modified with phosphorothioate 
(phosphorothioate-modified short ssDNA), and iii) a 50-base ssDNA that was chemically 
unmodified (long ssDNA).  Oligonucleotides with phosphorothioate linkages were chosen 
because this chemical modification minimizes enzymatic degradation by nucleases and 
increases antisense oligonucleotide activity.
223
 These chemically modified oligonucleotides 
have been extensively used both in vitro and in vivo.
223-225
  Because the phosphorothioate-
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modified short DNA sequence is used to downregulate GFP in vitro, we needed to ensure 
that it could be released from the vector in a manner similar to the non-modified DNA.  The 
short and long ssDNA were designed to investigate the correlation between sequence length 
and releasing profile.  
 
 
Short ssDNA 5'-GAGCTGCACGCTGCCGTC-3' 
Phosphorothioate-
modified short ssDNA 
5'-*A*G*C*T*G*C*A*C*G*C*T*G*C*C*G*T*C-3' 
Long ssDNA 
5'-CGGCAATCAGGTTGACCGTACATC 
ATAGCAGGCTAGGTTGGTCGCAGTC-3' 
siRNA antisense strand 5'-AUAGACGUUGUGGCUGUUGUA-3' 
siRNA sense strand 5'-UACAACAGCCACAACGUCUAU-3' 
Table 6-1.  ssDNA and siRNA sequences used.*Phosphorothioate modification 
For the thermally-induced release of the three fluorescently-tagged ssDNAs from the 
NS-PLL delivery vector, the solution is slowly heated in a temperature-controlled water bath 
(Error! Reference source not found.). Light-induced release was measured with respect to 
the ambient temperature of the solution, which increases upon laser irradiation due to 
photothermal heating by the irradiated nanoshells.  
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Figure 6-2.  Thermal and laser-triggered release of ssDNA from Au nanoshell-PLL 
vector.  Thermal release (red circles) and light release (black squares) of (A) short 
ssDNA (18 bases), (B) Phosphorothioate-modified short ssDNA (18 bases), and (C) long 
ssDNA (50 bases). 
 
For all three ssDNAs studied, the laser irradiation resulted in ssDNA release at lower 
solution temperatures compared to thermal release (Error! Reference source not found.).  
The release of some of the ssDNAs was detected immediately upon laser irradiation (Error! 
Reference source not found., black squares).  In contrast, for the thermal treatment (red 
94 
 
 
 
dots), the ssDNA was released gradually as the solution temperature was increased.  For 
light-induced treatment, a significant number of ssDNA molecules are released below 37 
o
C.  
Achieving ssDNA release at or near 37
o
C (physiological temperature) is particularly 
important for avoiding hyperthermic cell death. 
226-227
   
The difference between thermal and light-induced release profiles does not 
necessarily reflect a difference in release mechanism. For both thermally-induced and light-
induced release, the solution temperature is recorded.  For light-induced release, the localized 
heating around each nanoshell results in a nonuniform thermal profile and the macroscopic 
solution temperature does not reflect the temperature at the illuminated nanoshell surface.  
Localized heating in the direct, nanoscale vicinity around the nanoshell could release the 
ssDNA prior to increasing the ambient solution temperature.  Additional nonthermal 
mechanisms may be involved, such as  photon-induced transfer of ‘hot’ electrons, generated 
by laser excitation, to the polylysine peptide.  This would reduce the electrostatic interaction 
between the polylysine and ssDNA and enable release with little or no temperature increase 
of the local environment.
217
 
We compare the total number of DNA molecules attached to a PLL-functionalized 
nanoshell, termed “loading capacity”, to the number of ssDNA molecules released from a 
nanoshell during the thermal and light release processes (Error! Reference source not 
ound.).  The loading capacity was determined by a previously reported method (See 
methods, supporting information).
115, 217
  The phosphorothioate-modified short ssDNA has a 
much higher loading capacity (8182 DNA molecule/nanoshell) compared to the short ssDNA 
(3050 DNA molecules/nanoshell), even though the DNA base composition and sequence 
length are identical (Error! Reference source not found.). This could be a result of the 
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hosphorothioate modification, which replaces a nonbridging oxygen in the phosphate 
backbone with a sulfur atom.  These additional sulfur atoms may potentially bind to the Au 
surface of the nanoshells, increasing the loading capacity of this molecule.  Despite its 
greater loading capacity, the number of molecules released per nanoshell is strikingly similar 
for both the phosphorothioate-modified short ssDNA (thermal release: 2345 DNA/nanoshell; 
light release: 1236 DNA/nanoshell) and the chemically unmodified short ssDNA (thermal 
release: 2357 DNA/nanoshell; light release: 1182 DNA/nanoshell).  This also suggests that 
some of the phosphorothioate-modified ssDNA strands are covalently attached to the Au 
surface through the sulfur group in the phosphorothioate modification, preventing its release 
under these conditions. Only the electrostatically associated oligonucleotides are released for 
the light-induced and the thermally-induced treatments in these experiments. 
Since the interaction between the ssDNA and PLL is predominantly electrostatic, the 
length of the DNA sequence should affect the profile of the release. Shorter oligonucleotide 
sequences should interact less strongly with PLL and thus be released at lower temperatures. 
To validate this hypothesis, we compared the release profiles of short (18 bases) and long (50 
bases) ssDNA (Error! Reference source not found.). For the thermal process, the short 
sDNA begins to release between 30-40°C (Error! Reference source not found.A), while 
the long ssDNA begins to release between 40-50°C (Error! Reference source not found.C).  
For the light-induced process, both the short and the long ssDNAs are released at a lower 
solution temperature relative to the thermal treatments.  The number of long ssDNA 
molecules released per NS (~800) is significantly lower than the number of short ssDNA 
molecules released per NS (~1180) although the loading capacities of the two sequences are 
similar (3200 molecules/NS) (Error! Reference source not found.).  This is expected due to 
96 
 
 
 
he increase in electrostatic interactions between the long ssDNA and PLL. These 
measurements were performed at the same ambient temperature with the same laser exposure 
time. Therefore, by varying the length of the polylysine and ssDNA, it should be possible to 
control the number of ssDNA molecules released into the system while keeping all other 
conditions constant. 
 
 
Loading Capacity 
(DNA/nanoshell) 
Light Release 
(DNA/nanoshell) 
Thermal Release 
(DNA/nanoshell) 
Short ssDNA 3050 1182 2357 
Phosphorothioate-
modified short 
ssDNA 
8182 1236 2345 
Long ssDNA 3189 799 1097 
Table 6-2.  Quantification of ssDNA loading capacity, light release and thermal release.   
 
Cellular Uptake of Nanoshell-Polylysine Delivery Vectors 
For effective delivery of antisense oligonucleotides and siRNA, the NS-PLL delivery 
vector must be uptaken within the cell and escape the endosome.  To facilitate cell uptake, 
the NS-PLL was incubated with H1299 cells for two hours in serum-containing cell culture 
medium.  After incubation, the cells were either fixed and cellular uptake was investigated 
using dark-field microscopy (Figure 6-3A) and  fluorescence microscopy (Error! Reference 
source not found.B), or the number of nanoshells uptaken per cell was quantified by 
inductively coupled plasma mass spectrometry (Error! Reference source not found.D). 
Nanoshells of this size both absorb and scatter light making them easily visible in dark-field 
microscopy as diffraction-limited bright spots (Figure 6-3A).  The cell membrane is marked 
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by the red fluorescence dye, Alexa Fluor 555 WGA (wheat germ agglutinin).  Error! 
Reference source not found.C shows the merged dark-field and fluorescence images 
demonstrating the colocalization of NS-PLL within cells.   
 
Figure 6-3.Cell uptake of NS-PLL delivery vectors in H1299 cells. (A-C) Dark-
field/fluorescence images showing (A) polylysine nanoshells (NS-PLL), (B) cell 
membrane stained red with Alexa Fluor 555 WGA, and (C) A and B merged together 
showing polylysine nanoshells uptaken in cells. (D) Quantification of the number of 
nanoshells per cell determined by Inductively Coupled Plasma Mass Spectrometry 
(ICP-MS) after a I2/KI gold etch procedure.  Error bars represent standard deviations 
(n = 5). 
 
Since neither dark-field nor fluorescence microscopy can definitively determine 
whether nanoshells are endocytosed or remain outside the cell but associate with the cell 
membrane, ICP-MS was used to confirm and quantify nanoshell cellular uptake. Uptake was 
quantified in H1299 cells respectively treated with three NS-PLL constructs: 1) polylysine 
nanoshells (NS-PLL), 2) polylysine nanoshells with phosphorothioate-modified short ssDNA 
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electrostatically attached (NS-PLL-ssDNA), and 3) polylysine nanoshells with siRNA 
electrostatically attached (NS-PLL-siRNA).  After a 12 hour incubation of these constructs, 
the media was aspirated off and the cells were washed twice with phosphate buffered saline.  
To eliminate noninternalized nanoshells, a Iodine/Potassium Iodide (I2/KI) etchant procedure 
was performed 
222
 (See methods, supporting information).  The etchant rapidly oxidizes any 
gold at the exterior of the cell membrane, and is nontoxic at low concentrations.  Using this 
method with ICP-MS, we detected that  277 ± 64 NS-PLL per cell, 198 ± 28 NS-PLL-siRNA 
per cell, and 141 ± 10 NS-PLL-ssDNA per cell were internalized in H1299 cells, respectively 
(Error! Reference source not found.D). In principle, combining the measurement of the 
number of internalized nanoparticles with the light-induced release profile can enable us to 
determine the number of oligonucleotides delivered within the cell. 
While repeating experiments to confirm reproducibility, the number of nanoshells 
uptaken was observed to vary among different samples.  We hypothesized that the cellular 
uptake depended on the surface charge of the polylysine nanoshell delivery vectors.  To 
investigate, we measured the zeta (ζ)-potential for each sample (Table 6-3).  A control 
sample of bare nanoshells has a negative ζ-potential (-23.23 ± 3.9 mV).  Attachment of PLL 
to the NSs results in a net positive ζ-potential (14.27 ± 3.6 mV).  After attachment of the 
negatively charged siRNA or ssDNA, the ζ-potential decreased accordingly.  Interestingly, 
the ssDNA causes a significantly larger decrease (0.28 ± 4.41 mV), indicating that a greater 
number of ssDNA molecules were attached to the NS-PLL compared to double-stranded 
siRNA molecules (10.74 ± 2.2 mV).  This was expected due to the higher affinity of the 
phosphorothioate-modified ssDNA to the NS-PLL complex.  There is also a significant 
difference in the conformation between single-stranded DNA and double-stranded siRNA, 
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which could possibly allow more of the smaller ssDNA sequences to bind to the polylysine 
compared to the larger double-stranded siRNA.   
 
Sample Surface Potential (mV) 
Nanoshells (NS) -23.23 ± 3.9 
NS-PLL 14.27 ± 3.6 
NS-PLL-siRNA 10.74 ± 2.2 
NS-PLL-ssDNA* 0.28 ± 4.4 
 
Table 6-3.  ζ-potential measurements. *Phosphorothioate-modified short ssDNA.  Error 
represents standard deviations (n=5). 
 
The highest cellular uptake was recorded with the NS-PLL sample with the highest 
positive ζ-potential, while the lowest cellular uptake was obtained for NS-PLL-ssDNA, with 
the lowest ζ-potential. This correlation between net positive charge of the particle and uptake 
highlights the importance of carrier surface chemistry to the uptake mechanism. 
Previous studies regarding the uptake of cationic peptides, polymers, and 
nanoparticles suggest an adsorptive endocytosis pathway.
228-231
  First, the positively charged 
polylysine-functionalized nanoshells adsorb onto the negatively charged cell membrane 
surface and are then internalized via endocytosis.   It was recently shown that adsorption of 
particles to the cell membrane is the rate-limiting step for this mechanism.
222
   Because the 
NS-PLL sample has the greatest positive charge, this is likely to increase its interactions with 
the cell surface and reduce the time needed for adsorption.  Therefore, a greater number of 
the NS-PLL particles are adsorbed onto the cell membrane and ultimately internalized.
222
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Downregulation of Green Fluorescence Protein in vitro  
To study the ability of the NS-PLL delivery vector to release RNAi  therapeutic 
oligonucleotides in vitro, fluorescence microscopy was used to visualize the release of 
fluorescently tagged ssDNA from NS-PLL within the H1299 lung cancer cells.  The NS-
PLL-ssDNA sample was incubated with H1299 cells in an identical procedure as the cell 
uptake studies presented earlier.  The ssDNA is tagged on the 5' end with Alexa Fluor 488, a 
green fluorophore.  After the two hour incubation, the media is aspirated off and replaced 
with fresh media.  Half of the cells do not undergo a laser treatment (Figure 6-4A) and the 
other half are irradiated with a laser treatment, 2.5 W/cm
2
 for 2 minutes (Figure 6-4B).  
Finally, the cells are fixed and the cell membrane is stained red by Alexa Fluor 555 WGA.  
Error! Reference source not found.A shows that without laser treatment the green 
fluorescence is very weak most likely because the Alexa Fluor 488 fluorescence is quenched 
due to the proximity of the ssDNA to the gold nanoshell surface.  In Figure 3B, the laser 
treatment results in an increased brightness of the green fluorescence because the ssDNA is 
released from the NS-PLL delivery vector which eliminates the quenching.  Additionally, in 
the laser treatment group, it appears that the green fluorescence is more spread throughout 
the cell, indicating that the DNA has escaped from the endosome.   
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Figure 6-4. Fluorescence images H1299 cells incubated with NS-PLL-ssDNA.  The 
ssDNA is fluorescently tagged with Alexa Fluor 488 (Green). (A) Without laser 
treatment, the green fluorescence is quenched due to the proximity of the ssDNA to the 
gold nanoshell surface. (B) With laser treatment, the ssDNA is released, which 
eliminates the quenching, resulting in brighter green fluorescence spread throughout 
the cell.   
 
The rupturing of the endosome in response to laser irradiation has been the subject of 
intense research recently.
232-234
  The light-controlled rupturing is dependent on both the laser 
intensity and time of laser irradiation.  For both high continuous wave (CW) laser intensity 
(~10
5
 W/cm
2
) and pulsed laser irradiation conditions, the photothermal properties of the 
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nanoparticle results in the heating of the surrounding environment, thus leading to endosomal 
membrane disruption.
233
For low CW laser intensity irradiation conditions, like the conditions 
used within this study (2.5 W/cm
2
 for 2 minutes), the increase in temperature is minimal 
suggesting a non thermal, photochemical mechanism.
69, 217
  Krpetić et al, recently showed 
that lower laser irradiation powers (<20 W/cm2 for 2 minutes) resulted in a minimal 
temperature increase and significant endosome damage.
232
  The authors concluded that by 
controlling the laser power and exposure time, highly selective localized damage can be 
inflicted to the endosomal membrane without inducing cell death.
232
  This endosomal escape 
is crucial for the therapeutic oligonucleotides to be effective. 
To study the ability of the NS-PLL delivery vector to controllably deliver RNAi  
therapeutic oligonucleotide in vitro, a lung cancer cell line (H1299-dsGFP/dsRFP) that 
expresses destabilized green fluorescent protein (GFP) and destabilized red fluorescent 
protein (RFP) was used. Destabilized fluorescent proteins were chosen because they have 
short half-lives that allow for monitoring of downregulation shortly after administration of 
the molecular therapeutics.
235-237
  The GFP was used as the target reporter for determining 
downregulation of gene and protein expression by phosphorothioate-modified single-
stranded antisense DNA oligonucleotide (AON-GFP) or siRNA specific to GFP mRNA 
(siRNA-GFP). The RFP served as a reference protein to ensure accurate measurements of 
GFP despite variations in fluorescence intensity due to variations in cell number.  This was 
achieved by designing the siRNA and antisense oligos to downregulate GFP without 
affecting the RFP.  Thus, for all measurements, the peak fluorescence intensity of GFP was 
normalized by the peak intensity of RFP (GFP/RFP).
237
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Three separate polylysine nanoshell complexes were prepared: NS-PLL, NS-PLL-
siRNA, and NS-PLL-ssDNA.  Here, the ssDNA was identical to the phosphorothioate-
modified short ssDNA used in the extracellular release studies described earlier.  The 
antisense oligonucleotides and siRNA sequences used in these experiments were chosen 
from previous studies and have been previously investigated for specificity 
27, 236, 238
 and, 
furthermore, were compared to scrambled sequences to ensure specific downregulation of 
GFP (Figure 6-5).  
 
Figure 6-5.  GFP/RFP (%) of H1299-GFP/RFP cell line treated with DharmaFECT 2 
transfection reagent, DharmaFECT 2 with phosphorothioate-modified short ssDNA 
DharmaFECT 2 with phosphorothioate-modified scrambled short ssDNA, 
DharmaFECT 2 with siRNA and DharmaFect 2 with scrambled siRNA.   
 
The downregulation of GFP by antisense oligonucleotides (Error! Reference source 
not found.A) and siRNA (Error! Reference source not found.B) delivered via NS-PLL 
delivery vectors was monitored by measuring the peak fluorescence intensity of both GFP 
and RFP at specific time points: prior to incubation (0 hours), after incubation and prior to 
laser treatment (12 hours), and after laser treatment (15, 18, 24, and 36 hours).  The laser 
treatment for the NS-PLL sample, which had neither siRNA nor ssDNA attached, resulted in 
negligible GFP downregulation (Error! Reference source not found.C, NS-PLL).  In 
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figures 3A and 3B, the “with laser” and “without laser” are normalized percentages to the 
“with laser” and “without laser” of the NS-PLL sample, respectively.  During the incubation 
period (0-12 hours), GFP expression was downregulated by antisense ssDNA to 72 ± 5% 
(Error! Reference source not found.A) and by siRNA to 80 ± 5% (Error! Reference 
source not found.B).  This downregulation was likely due to the AON-GFP and siRNA-GFP 
partially bound to the PLL which came off the delivery vector during cell incubation.  At 12 
hours, half of the cells were irradiated with the laser for 2 minutes.  At 18 hours, six hours 
after laser treatment, GFP downregulation for the laser-treated samples had reached its 
minimum (~47% for antisense ssDNA and ~49% for siRNA, Error! Reference source not 
found.C).  Therefore, the laser-treated samples resulted in an additional ~23% and ~31% 
GFP downregulation for antisense ssDNA and siRNA, respectively, when compared to the 
non-laser treated samples.  This difference in downregulation indicates that the laser 
treatment controllably released the gene therapeutics from the NS-PLL delivery vector. The 
samples not treated with the laser showed no further downregulation after the incubation 
period. In fact, GFP expression increased shortly after incubation, indicating that the initial 
downregulation observed during incubation was limited to the ssDNA or siRNA released 
during incubation.  Because GFP is continuously produced and expressed within the cell, 
after the ssDNA or siRNA is consumed, the GFP/RFP percentage gradually increases, 
approaching its pretreatment value after 24 hours following laser irradiation.   
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Figure 6-6. Downregulation of green fluorescent protein (GFP) in H1299 GFP/RFP cell 
line by antisense ssDNA and siRNA using Nanoshell polylysine (NS-PLL) delivery 
vectors. (A, B) Percent GFP/RFP fluorescence as a function of time with and without 
laser treatment for NS-PLL delivery vectors carrying with (A) Antisense ssDNA and 
(B) siRNA. (C) Percent GFP/RFP fluorescence at 18 hours (6 hours after laser 
treatment). Data displayed as mean ± SEM (n=3).  Unpaired t-tests: *P = 0.5934, **P = 
0.0176, ***P = 0.1071. 
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The observed magnitude of the downregulation of GFP is similar for both delivery 
vectors, despite their difference in ζ-potential.  The data in Table 6-3 suggests that fewer 
siRNA molecules are attached to the NS-PLL delivery vector compared to antisense ssDNA, 
because the NS-PLL-siRNA sample has a higher positive ζ-potential.  However, Error! 
Reference source not found.C shows that both samples had ~50% downregulation of GFP 
when treated with the laser.  This observation correlates well with studies showing that 
siRNA is more efficient in silencing genes and downregulating their proteins expression 
relative to phosphorothioate-modified antisense ssDNA.
223, 236
   Interestingly, we observed a 
greater downregulation of GFP for light-triggered release of RNAi oligonucleotides when the 
cells were trypsinized prior to  laser treatment compared to adhered cells (data not shown).  
Any effect that this trypsin procedure would have on protein expression is negated because 
the GFP downregulation data shown in Figure 6-6 is normalized to the NS-PLL group that 
also underwent the trypsin procedure.   
From a kinetic point of view, GFP downregulation reaches its maximum at 
approximately 6 hours after laser treatment.  This time frame for observing GFP 
downregulation is consistent with both experimental and theoretical results that used 
antisense oligonucleotides and siRNA to downregulate short half-life destabilized 
proteins.
235-237
 Additionally, the light-triggered delivery process is significantly different 
from traditional passive transfection reagents such as liposomes and dendrimers.  With a 
transfection reagent, the delivery of the RNAi oligonucleotides occurs over multiple hours, if 
not days, because these RNAi oligonucleotides must slowly escape the endosome, dissociate 
from the transfection reagent, and finally diffuse to the mRNA in the cytosol.  In the case of 
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light-triggered delivery, the vast majority of the oligonucelotides is released during the short 
laser irradiation treatment (2 minutes).  Therefore, it is likely that the gene silencing and the 
subsequent protein expression downregulation occurs faster due to the higher initial 
concentration of released RNAi oligonucleotides in the cytosol of cells.  Further studies 
would be needed to determine if light-induced processes, or combinations of light-controlled 
processes, could be used to more generally modify cellular processes in this manner. 
In estimating the amount of therapeutic RNAi oligonucleotides delivered, we 
hypothesize that the percentage of the RNAi oligonucleotides released intracellularly is 
similar to the extracellular release, in which a maximum of ~1200 ssDNA were released per 
nanoshell. This hypothesis is theorized since the laser radiation takes place within the “water 
window,” where water and tissue are maximally transparent, such that the cellular 
environment should have a minimal effect on the NS response to laser irradiation. 
39
  
Additionally, the release of the RNAi oligonucleotides is due to either the local heat 
generated around the nanoshell or the generation of hot electrons on the gold surface, neither 
of which should be affected by the cellular environment.   If this hypothesis is correct, by 
using the ICP-MS nanoshell uptake result for NS-PLL-ssDNA (~141 nanoshells/cell) and the 
number of ssDNA released extracellularly below 37°C (~1000 ssDNA/NS),  then a 
maximum of ~141,000 antisense oligonucleotides would be released inside the cell.  After 
converting this number to moles and dividing by the intracellular volume (4x10
-12
 L)
235, 239
, 
we can estimate that ~ 60 nM of antisense oligonucleotides are delivered inside each cell via 
light-triggered release from the NS-PLL vector.   This approximate concentration correlates 
well to the ~50% GFP downregulation we observed, according to both previously reported 
experimental results and theoretical models.
235-236, 240
  Although this is an approximation, it 
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points to future capabilities for delivering known amounts of therapeutic molecules using 
vectors such as our polylysine nanoshell complex at specific time points, to study the kinetics 
of physical, chemical, and biological processes within live cells.  The efficiency of the 
polylysine nanoshell delivery vector demonstrated here can be improved by increasing the 
intracellular uptake, optimizing laser irradiation conditions, and the integration of targeting 
moieties for studies in vivo.   
 
Cell Viability Assay 
The cell viability of the H1299-GFP/RFP cell line after incubation with the polylysine 
nanoshell delivery vectors and subsequent laser treatment was investigated by using a XTT 
assay (Figure 6-7).  Incubation of the nanoshell-polylysine delivery vectors with no laser 
treatment resulted in 82 ± 6% cell survival.   After laser irradiation, there was 88 ± 7% cell 
survival, indicating that the laser treatment is not detrimental to the cells.  This may come as 
a surprise considering Au nanoshells are well known for photothermal cancer therapy, but the 
laser power and exposure time used in this study (1.27 W/cm
2
, 2 min) were significantly less 
than those used for photothermal induction of cell death (4W/cm
2
, 3-6 min).
15, 78, 214, 227
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Figure 6-7.  Analysis of NS-PLL nanoparticle-associatedcytotoxicity by XTT assay.  
Percent survival of H1299 cells with no treatment compared to cells incubated with 
Nanoshell-Polylysine (NS-PLL) delivery vector without laser treatment (w/o Laser) and 
with laser treatment (w/ Laser), mean ± standard deviation (n=3). Unpaired t-tests: *P 
= 0.1237, **P = 0.3747.   
 
The NS-PLL sample was chosen for cell viability because this sample had the 
greatest uptake of nanoshells, and therefore it would have had the greatest possibility to 
cause photothermal cell death.  The small decrease in the percent of cell survival in the non-
irradiated sample could possibly result from a variety of factors, including the high ζ-
potential of this sample or free polylysine that is not attached to the nanoshell.
241
  
Additionally, nanoparticle concentration and incubation time have been shown to affect cell 
viability.
242
  Cationic transfection reagents that show low toxicity are often linked with 
polyethylene glycol (PEG), which reduces toxicity without affecting transfection efficiency, 
but attachment of PEG to our NS-PLL platform has yet to be investigated. 
6.3. Conclusions  
In this work, we have quantitatively demonstrated the remotely-controlled, light-
triggered release of antisense ssDNA from polylysine nanoshell vectors.  The cellular uptake 
of the NS-PLL complex in H1299 lung cancer cells was investigated by fluorescence 
microscopy, dark-field microscopy, and ICP-MS.  This polylysine nanoshell complex was 
successfully used as a nonviral delivery vector that could controllably release antisense 
oligonucleotide ssDNA and siRNA to silence the target reporter GFP gene and downregulate 
GFP protein expression in vitro.  One particulary important aspect of this NS-PLL delivery 
vector is the laser treatment results in escape from the endosome. Neither the polylysine 
nanoshells nor the laser treatment showed any significant evidence of cytotoxicity, indicating 
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that this nanoparticle complex may be a useful delivery vector for RNAi molecular 
therapeutics.  This complex could further be used to quantify the number of molecules 
delivered intracellularly, which could have extensive applications in studying the rates of 
specific processes within living cells. 
6.4. Experimental Methods 
 Nanoshell synthesis. Au nanoshells were synthesized according to a previously 
published method.
35
 The dimensions of the silica core and the Au shell ([r1, r2] = [60, 82] nm) 
were designed so that the peak plasmon resonance in an aqueous suspension occurred at 800 
nm, corresponding to the laser excitation wavelength used in this experiment (Fig. S1, 
Supporting Information).  The concentration of nanoshells in water is determined by the 
following equation which is derived from beer's law:  
b
A303.2# peak
x
x
mL
Nanoshells
ext
  
where A peak=experimental absorption at the peak plasmon resonance wavelength, σext = 
theoretical extinction cross section at the peak plasmon resonance wavelength taken from 
Mie theory, b = path length of the cuvette in centimeters.   
 Polylysine Attachment to Nanoshells. The Cysteine (C)-Tyrosine (Y)-Serine (S)-
Lysine(K)50 (PLL) peptide was custom synthesized (Biomatik USA, LLC) The peptide was 
received as a lyophilized powder and resuspended in Milli-Q water to a concentration of 500 
μM.  Once the concentration of nanoshells is known, this PLL peptide is added to the 
solution of nanoshells in 100,000 molar excess of PLL.  This solution was allowed to 
incubate for 24 hours on a rocker at room temperature. The excess PLL was removed via two 
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centrifugation cycles (350 rcf for 15 minutes) and resuspended in Milli-Q water.  ζ-potential 
measurements confirmed PLL attachment (Table 6-3).   
 ssDNA or siRNA loading.  Antisense ssDNA and siRNA were custom synthesized 
by Integrated DNA Technologies, IDT and Qiagen, respectively.  ssDNA and siRNA was 
resuspended in TE buffer and nuclease-free water, respectively, to a final concentration of 
~100 µM. An 50,000 molar excess of ssDNA or siRNA was added to the Au nanoshell/PLL 
suspension previously prepared and allowed to incubate for 24 hours on a rocker at room 
temperature.  The nanoshell solution was placed in the refrigerator at 4°C and allowed to 
gently settle down for 48 hours. Afterwards, the supernatant was pipetted off and the pellet 
was resuspended in Milli-Q water. (Note: For the fluorescein-tagged-ssDNA release 
experiments, resuspension in TE buffer (IDT, pH=7.5) is necessary to ensure that the pH is 
constant since the emission properties of fluorescein are pH dependent.) 
 Loading Capacity of Fluorescently-tagged ssDNA on the NS-PLL vector.  Two 
aliquots of 500 uL of NS-PLL-ssDNA were pipettes into two separate 1.5mL eppindorf 
tubes.  In one tube, 500 uL of TE buffer was added and in the other tube 500 uL of 12mM 
mercaptoethanol (diluted in TE buffer) was added.  Both tubes were covered in aluminum 
foil and were gently mixed on a rocker plate for 24 hours.  Mercaptoethanol displaces the 
polylysine and ssDNA attached to the nanoshell. After 24 hours, both samples were 
centrifuged to remove the nanoshells, then the supernatants were measured in a fluorolog 
(excitation wavelength:  495 nm, Emission wavelengths: 505-540 nm).  The difference in 
fluorolog intensity between samples was used to calculate the difference in DNA 
concentration by using a standard curve of DNA concentration versus fluorescence intensity.  
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The DNA concentration was then divided by the nanoshell concentration, which is calculated 
by UV-VIS absorbance measurement.   
 Thermal and light-triggered release of ssDNA.  Thermal release was performed by 
slowly heating the NS-PLL-ssDNA sample (~1°C/min) while stirring, ensuring that the 
sample temperature was homogeneous during the entire course of the measurement.  The 
light release was performed by placing a fiber-coupled 800 nm continuous wave laser above 
the sample and stirring during laser irradiation.  For both thermal and laser treatments, the 
solution temperature was monitored with a thermocouple.  The release of the fluorescently 
tagged ssDNA was quantified by taking aliquots out of the sample as the solution 
temperature increased.  Each aliquot was centrifuged immediately to separate the nanoshells 
from the released ssDNA in the supernatant and the fluorescence intensity of the supernatant 
was measured to determine the number of released ssDNA per nanoshell.   
 Cell culture. The H1299 and H1299-GFP/RFP lung cancer cell lines were incubated 
at 5% CO2, 37°C with RPMI 1640 media with L-glutamine supplemented with 10% heat-
inactivated fetal bovine serum and 1% antibiotic solution.  0.25% Trypsin-EDTA was used 
for cell passaging.   
 NS-PLL cellular uptake. The H1299-GFP/RFP lung cancer cells were seeded in 4-
well chamber slides at 5000 cells/well 24 hours prior to incubation with NS-PLL delivery 
vectors. The nanoshells were added to the serum containing media in a NS:cell ratio of 
5,000:1 and allowed to incubate for 2 hours.  Then, the cell culture medium was aspirated 
off, the cells were washed twice with 1x phosphate buffered saline, the cells were fixed with 
4% paraformaldehyde, and stained with Alexa Fluor 555 according to manufacturer 
instructions.  The walls of the chamber slide were removed, and the cells were mounted 
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using Vectashield mounting medium for fluorescence (Vector Laboratories)  and 22x50 mm 
rectangular cover glass (n=1.5)  Dark-field and fluorescence images were taken on a 
Cytoviva microscope equipped with dual-mode fluorescence module and a x-cite light 
source.  For quantification of nanoshells uptaken in cells, ICP-MS measurements were 
performed. After a 12 hour incubation, the media was aspirated off, the cells were washed 
twice with PBS, the I2/KI etchant procedure was perfomed (see methods, supporting 
information), live cells were sorted and counted using flow cytometry, digested with aqua 
regia, and then the gold content was measured with the ICP-MS (see methods, supporting 
information).   
 Fluorescence images for light-triggered release.  NS-PLL-ssDNA delivery vectors 
were incubated with cells in an identical manner to NS-PLL uptake.  The ssDNA is 
fluorescently tagged with Alexa Fluor 488 (Integrated DNA technologies, IDT) After two 
hours, the media was aspirated off, the cells were washed twice with 1x phosphate buffered 
saline, fresh media was added.  The laser treatment group under went a laser treatment (2.5 
W/cm
2
, 2 minutes).  Immediately afterwards, the media was aspirated off, fixed, and stained 
in an identical procedure as the NS-PLL cellular uptake experiments and imaged with a 
Cytoviva microscope. 
 Laser treatment for GFP downregulation.  H1299-GFP/RFP cells were plated in a 
12-well plate at a density of 95,000 cells/well 12 hours before incubation with NS-PLL, NS-
PLL-ssDNA, and NS-PLL-siRNA delivery vectors.  These NS-PLL delivery vectors were 
incubated with cells in an identical manner as the NS-PLL cell uptake experiments.   After 
incubation the cell culture media was aspirated of, the cells were washed with PBS, 
trypsinized, and resupsended in cell culture media.  Half of each cell suspension was 
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irradiated with an 800 nm CW laser for 2 minutes at 2.5 W/cm
2
 and the other half did not 
undergo laser irradiation.  The cells are then plated back onto a fresh 24 well plate.  Green 
Fluorescence Protein (GFP) and Red Fluorescence Protein (RFP) were measured at specific 
time points using a fluorescence plate reader.   
 GFP/RFP measurements.  Green Fluorescence Protein (GFP) and Red Fluorescence 
Protein (RFP) were measured using a Fluorescence plate reader (Biotek FLx800).  For GFP 
the excitation filter was 485/20 nm and emission filter was 530/25 nm.  For RFP the 
excitation filter was 530/25 and emission filter was 590/35 nm.   GFP and RFP 
measurements were take prior to incubation (0 hours), after incubation and prior to laser 
treatment (12 hours), and after laser treatment (15, 18, 24, and 36 hours).  
 Instrumentation.  Extinction spectra were obtained using a Cary 5000 UV/Vis/NIR 
spectrophotometer. Fluorescence emission of fluorescently tagged ssDNA was obtained 
using Jobin Yvon Fluoromax 3.  Biotek FLx800 was used for microplate fluorescence 
measurements.  Perkin Elmer ELAN9000 Inductively Couples Mass Spectrometer.  Flow 
cytometry was done on a BD FACS Aria II.  
 Inductively-Coupled Mass Spectrometry Measurements.  The I2:KI etchant was 
made by mixing Iodine (I2, Aldrich) and potassium iodide (KI, Aldrich) to deionized water 
with a molar ratio of 1:6. The major role of KI is to increase the solubility of I2 in water. 
Cells were initially seeded in 6-well plates at a density of 400,000 cells/well 24 hours prior to 
incubation with nanoshell-dsDNA-DAPI complexes. The nanoshells were added to the serum 
containing media in a NS:Cell ratio of 5,000:1 and allowed to incubate for 12 hours.  Then 
media was aspirated off.  The sample was washed with PBS three times, and 1 mL of the 
I2/KI etchant (0.17 mM of I2) was added to the well. After etching at room temperature for 5 
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min, the solution was removed, the culture plate was washed with 3 times with 2 mL PBS.  
500 uL 0.25% Trypsin-EDTA was added.  After visual detachment of cells, the trypsin was 
deactivated by adding 500 uL serum-containing media.  This suspension was then analyzed 
by flow cytometry for viable healthy cells using  Propidium Iodide (PI).  PI only enters cells 
apoptotic and necrotic cells which have damaged membranes, binds to the DNA in the 
nucleus and fluoresces red.  PI is excluded from healthy cells.  100,000 cells viable cells 
(cells that did not fluoresce red) were sorted into a 20-ml scintillation glass vial.  
Concentrated Aqua regia was added to each glass vial and allowed to sit overnight.  (Aqua 
regia is made of 3:1 of Hydrochloric acid (Sigma Aldrich, 37 wt. % in H2O, 99.999% trace 
metals basis):Nitric Acid(Sigma, 70%, ≥99.999% trace metals basis).  WARNING: Aqua 
regia is dangerous and should be used in a chemical hood because it produces toxic nitrosyl 
chloride and chlorine gases.  Do not cap the aqua regia because it produces gases and will 
explode if capped.  The next day, the aqua regia was boiled off by using a hot plate inside of 
a chemical hood.  Each vial was then resuspended in 1% Aqua regia and filtered with 0.2 µm 
filters (PALL Acrodisc 32 mm).  Au content was measured via ICP-MS in ppb and then 
converted to gAu. 
 Calculation for Number of nanoshells uptaken.  Prior to PLL attachment, the silica 
core radius and Au shell radii were measured from particle size statistics obtained from SEM 
images of over 100 silica core particles and 100 Au nanoshells.  The size of nanoshells (NS) 
=  [r1, r2] nm.  The Volume of the Au shell per NS was then calculated: Volume of Au 
shell/NS= (4/3)π(r2
3
-r1
3
) cm
3
).  The grams of Au/NS was then calculated: grams of Au/NS (
NS
gAu
 ) =Volume of Au shell/NS*(Density of Au (19.3g/cm
3
)),  Flow cytometry gives a 
specific number of cells (# cells).  Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) 
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was used to quantify grams of Au ( gAu ).  The number of nanoshells per cell was then 
calculated: (#NS/cell)=
cells
NS
gAu
gAu
#
 
 XTT assay.  After the laser treatment the cells were allowed to grow for 12 hours, 
and then the XTT assay (sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino)-carbonyl]-2H-tetrazolium inner salt) was performed according to XTT kit 
instructions (ATCC). 
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Chapter 7 
 
Conclusions 
The controlled release of biological and nonbiological molecules could have broad 
applications in the study of cellular processes and in the development of intracellular targeted 
therapies.  Herein, we have shown light-triggered controlled release of DNA, siRNA and 
DAPI, a fluorescent molecule that intercalates within dsDNA, from plasmon-resonant 
nanoparticles.   
The light-triggered release of the ssDNA, either from dsDNA dehyhybrization 
attached to  the Au nanoparticle surface or desorption from polylysine nanoshells, was 
investigated by using fluorescently-tagged DNA.  Then, the increase in fluorescence 
intensity, which correlates to release of ssDNA, was monitored as a function of either 
solution temperature or time.  The thermal treatment release, performed by monitoring the 
DNA release as the solution temperature slowly increases (1°C/min), resulted in definitive 
release of DNA at elevated temperatures.  For laser treated samples, the solution temperature 
was also monitored with a thermocouple, and it was observed that ssDNA release occurred at 
lower solution temperatures compared to the thermal treatment.  The difference in release 
behavior between thermal and laser treated samples suggest either a non-equilibrium thermal 
mechanism or a non-thermal mechanism.   
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To study the mechanism in more detail, light-triggered dehybridization release of 
dsDNA was compared between dsDNA attached to Au nanoshells and Au nanorods.  For 
dsDNA attached to Au nanoshells, the light-triggered release is observed to occur at a lower 
solution temperature compared to the thermal release profile.  Surprisingly, the light-
triggered release and thermal release profiles for dsDNA attached to Au nanorods were 
identical.  Theoretical calculations were performed to estimate the temperature on the 
nanoparticle surface for the experimental laser irradiation conditions used.  The theoretical 
temperature increase on the surface of nanoshells and nanorods was calculated to be less than 
1 degree Celsius, which suggests that a nonequilibrium thermal mechanism is unlikely.  The 
alternative non-thermal mechanism suggests that charge transfer can occur via the excitation 
of hot electrons that transfer to the attached dsDNA, which destabilizes the dsDNA by 
increasing the columbic repulsion.  After calculating the near-field enhancements and 
absorption cross sections for a nanoshell and a nanorod, it was found that nanoshells have a 
higher absorption cross section and a near-field enhancement which covers a larger volume 
of the nanoparticle surface.  These two qualities of a nanoshell increase the probability of 
charge transfer to occur on a nanoshell in comparison to a nanorod.   
Additionally, we have shown the dsDNA attached to the Au nanoshell surface can be 
used as a “host” structure to carry a "guest” molecule.  In our system, the dsDNA carried 
DAPI, a small organic fluorescent molecule commonly used in fluorescence microscopy due 
to its strong association to dsDNA.  After dsDNA was attached to nanoshells, an excess of 
DAPI molecules were added to the sample and the DAPI molecules intercalated into the 
dsDNA.  After the NS-dsDNA-DAPI nanoparticles are endocytosed by the H1299 lung 
cancer cells, the laser treatment was performed.  We hypothesized that if the dsDNA is 
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dehybridized during the laser irradiation, the intercalated DAPI molecules would dissociate 
and diffuse to the nucleus and bind to the genomic DNA.  To test this hypothesis, using flow 
cytometry we measured the fluorescence intensity of the nucleus before and after laser 
irradiation and we observed an increase in fluorescence intensity.  This nanoshell-dsDNA 
system could be extended to a multitude of other guest molecules that associate with the host 
dsDNA carrier including small organic fluorophores, steroid hormones, and therapeutic 
molecules.   
Finally, we design a non-viral delivery nanoparticle, which consists of cationic 
polylysine peptide attached to Au nanoshells.  The negatively charged ssDNA and siRNA 
electrostatically attaches to the positively charged polylysine.  Upon laser irradiation at the 
plasmon resonance wavelength of the nanoshell, the electrostatic attraction is broken.  We 
demonstrate the controllable light-triggered delivery of both ssDNA and siRNA and 
subsequent GFP protein downregulation within a H1299 lung cancer, GFP-expressing cell 
line in vitro.  Light-triggered delivery resulted in ~ 47%  and ~49% downregulation of the 
targeted GFP expression by ssDNA and siRNA, respectively.  Cytotoxicity induced by both 
the polylysine nanoshell delivery vector and the laser irradiation is minimal, as demonstrated 
by a XTT cell proliferation assay.   
Hopefully, this work has laid the groundwork for future applications towards light-
triggered controllable release of small molecules, gene therapeutics, proteins, and other 
biologically relevant molecules.  Because this light-triggered release is based upon a host-
guest complex attached to a plasmonic particle, additional attachment techniques 
undoubtedly will be investigated.  Light-triggered release has the advantages of delivering 
molecules with temporal and spatial control, which could minimize drug side effects and 
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increase efficacy.  With additional experiments and optimization, this delivery strategy has 
the capability to become another tool for clinicians to use towards treating a multitude of 
genetic diseases.   
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Appendix A: Supplementary Figures 
 
Figure A-1. Effect of thermal and laser treatments on Au-thiol bond stability.  (A) Schematic of 
fluorescein-tagged, thiolated ssDNA attached to a NS. (B) The fluorescence spectrum of the 
supernatant before (black line) and after (red line) displacement by mercaptoethanol (MCE) of 
the fluorescein-tagged, thiolated ssDNA.(C) Peak fluorescence intensity (λ = 520nm) of 
fluorescein in the supernatant as a function of solution temperature for thermal treatment 
(black squares) and laser treatment (red dots). The dashed line (-----) corresponds to complete 
release, determined by the peak at 520nm from the red curve in (B).  
 
Figure A-2. ssDNA release from dsDNA-NRs with surface coverage of 120 DNA/NR.  
Fluorescence intensity (a.u.) versus solution temperature (°C). 
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Appendix B: Protocol for Nanoshell Synthesis 
1) Preparing 1% (m/V) Au(III) Chloride Hydrate Salt Solution 
1.1) Before nanoshells can be synthesized, the necessary Au(III) Chloride Hydrate 
solution and 2-3 nm THPC Au colloid needs to be made.   
1.2) Prepare a 1% mass/volume (0.02943 M) Au salt solution by adding 
approximately 5 mL of deionized water to the newly opened 5g bottle of Au(III) Chloride 
Hydrate (HAuCl4, Sigma Aldrich, 99.999%) and vortex until completely dissolved.  Then 
dilute this 5 mL solution to 500 mL by using a volumetric flask.  Store this solution in an 
amber glass bottle, in a dark cabinet at room temperature, and allow it to age for at least 10 
days before use.  This solution is good for at least a year, as long as it is stored in the dark at 
room temperature. 
2) Preparing 2-3 nm THPC Au Colloid Solution
243
  
2.1) Make a 251.4 mM solution of Tetrakis(hydroxymethyl)phosphonium chloride 
(THPC) in water by adding 400 μL of  THPC (Sigma Aldrich, 80% (w/w) in H2O) to 33 mL 
of deionized water. 
2.2) Separately, measure 180 mL of deionized water and pour it into a 250 mL flat 
bottom beaker. Under vigorous stirring add 1.2 mL of 1M NaOH (Acros Organics) followed 
by 4 mL of the 251.4 mM THPC solution.  Allow the solution to stir vigorously for 5 
minutes. 
2.3) While waiting, measure out 6.75 mL of the 1% (m/v) Au(III) Chloride Hydrate 
salt solution into a small beaker.  After waiting the 5 minutes, under vigorous stirring, in one 
quick motion, add the 6.75 mL of the 1% (m/v) Au salt solution.  The color of the solution 
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changes instantly from colorless to brown.  Store the solution in a capped container at 4°C 
and allow it to age for at least 14 days.  This THPC Au colloid solution produces the best 
nanoshells when used from 14 days – 8 weeks old.   
3) Synthesis of the Silica Cores 
3.1) Spherical Silica cores can either be synthesized or purchased commercially.  For 
highly reproducible results, buying commercial cores is recommended, especially if your 
primary interest is in one particular nanoshell size and resonance; however the size of the 
silica cores and the polydispersity should always be checked either by Scanning Electron 
Microscopy (SEM) or by Dynamic Light Scattering (DLS).  The standard deviation should 
be less than 5% and definitely not exceed 10%.   
3.2) The following synthesis of silica cores is commonly called the Stöber recipe
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and reliably produces spherical silica particles with diameters between 70 and 800 nm.  If 
you need particle sizes outside of this range consult the literature for additional silica particle 
protocols. 
3.3) Distill Tetraethylorthosilicate (TEOS Sigma Aldrich 99.99%) if desired.  In order 
to make very monodisperse silica particles it is necessary to distill the TEOS.  Distillation 
will result in silica particles with 5-10% polydispersity. 
3.4) The following procedure makes 120 nm diameter silica particles.  To make silica 
particles with different sizes refer to the literature for the correct ratios of ethanol, 
ammonium hydroxide, and tetraethylorthosilicate.  Nanoshells can be synthesized on 
different sized silica particles.  When changing to a different sized core, the centrifuge speeds 
will vary.  See table B-1 for suggested centrifuge speeds.   
124 
 
 
 
3.5) Measure out 100 mL of 200 proof ethanol and pour it into a clean 200 mL 
polypropylene bottle.  Add 5.7 mL of ammonium hydroxide (Sigma Aldrich, 28% NH3 in 
H2O).  Under vigorous stirring, add 1.5 mL of tetraethylorthosilicate (TEOS) (Sigma Aldrich, 
99.999%).  Allow to react for 8 hours or overnight.   
3.6) Measure the size of the silica particles by a Scanning Electron Microscope 
(SEM), a Tunneling Electron Microscope (TEM), or Dynamic Light Scattering (DLS) 
instrument. The polydispersity should be less than 5% and not exceed 10%.   
3.7) The silica particles are washed by centrifugation.  Centrifuge speeds vary with 
silica particle size (Table B-1).  For 120 nm diameter silica particles, centrifuge at 3500 rcf 
for 30 minutes.  After centrifuging, pour off the excess supernatant.  Resuspend the silica 
particles into 40 mL of deionized water with a probe sonicator (Do not allow the solution to 
become warm). Repeat the centrifugation and resuspension in water again.  
3.8) Centrifuge again and resuspend the silica particles in 40 mL of 200 proof 
ethanol.  Repeat the centrifugation and resuspension in ethanol again.  Centrifuge once more 
and resuspend in ethanol to a volume of 40 ml. 
 
Silica Diameter (nm) Silica nanoparticles Seed Nanoshells 
80 nm 6000 rcf 3000 rcf 600 rcf 
120 nm 3500 rcf 1500 rcf 350 rcf 
180 nm 1500 rcf 800 rcf 200 rcf 
270 nm 1000 rcf 500 rcf 70 rcf 
Table B-1. Suggested Centrifuge Speeds for silica particles, seed particles, and 
nanoshells dependent upon silica particle diameter.  
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4) Functionalizing the Silica Cores with 3-Aminopropyltriethoxysilane 
4.1) Once the silica core particles are complete they have to be coated with 
aminopropyltriethoxysilane (APTES) (Sigma Aldrich, 99.99%).   
4.2) Pour the 40 mL of silica particle/ethanol suspension into a 50-mL clean 
polypropylene bottle.  Under vigorous stirring, add the APTES and wait 10 minutes, then 
decrease the stirring speed and stir for 8 h or overnight.  
4.3) After stirring overnight, pour the solution into a clean glass beaker and place on a 
hot plate.  Using low heat, bring the solution to a boil.  Boil for 1 hour.  Total evaporation of 
the ethanol solvent during boiling is prevented by the continuous addition of ethanol.  
4.4) Clean the APTES functionalized cores with 3 steps of centrifugation and 
resuspension in 200 proof ethanol.  The final resuspension in ethanol should be to a volume 
of 10 mL.  These APTES functionalized silica cores can be used for 3 or more years as long 
as the solution is capped tightly and sealed with parafilm, which ensures the silica cores will 
not dry out.   
5) Making the “Seed” Particles: Attachment of THPC Au Colloid to APTES 
Functionalized Silica Particles 
5.1) Before a Au shell can be grown around the silica cores, the 2-3 nm THPC Au 
colloid needs to be attached to the outside of the APTES-functionalized silica particles.   
5.2) Prepare 5 mL of 1M NaCl solution in deionized water.  Measure out 40 mL of 
aged THPC Au colloid solution into a 50 mL centrifuge tube.  Sonicate the APTES 
functionalized cores with either a probe sonicator or a bath sonicator for 1-2 minutes.   
5.3) Using two micropipettes, add 1 mL of the 1M NaCl solution to the THPC Au 
colloid solution, followed immediately by 400 uL of the APTES-functionalized silica 
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particles.  Quickly cap the centrifuge  tube, vortex, and place in a bath sonicator at medium 
power for 2 minutes.  Take out and let the solution sit at room temperature for a minimum of 
8 hours to a maximum of 48 hours.    
5.4) To remove the excess THPC Au colloid, centrifuge at 1500 rcf for 15 minutes 
(Centrifuge speeds will vary with particle size, Table B-1).  The supernatant will still be a 
dark brown color, but the darker soft pellet should be visible at the bottom of the centrifuge 
tube. Carefully pipette off the supernatant and resuspend the seed particles in deionized water 
by vortexing and bath sonication at medium power.  
5.5) Repeat centrifugation and resuspension until the supernatant is colorless. Two 
centrifugation and resuspension cycles typically works fine.  Three centrifugation and 
resuspension cycles is the maximum. The final resuspension should give a UV-Vis extinction 
(absorbance) measurement of 1.0 with a cuvette path length of 1 cm (Figure B-1).  This 
solution can either be used immediately for nanoshell synthesis or can be stored, for later use, 
at 4°C for 2-3 months. 
 
Figure B-1. UV-Vis extinction spectrum of seed solution. 
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6) Preparing Au Salt/Potassium Carbonate Electroless Plating Solution 
6.1) The Au shell is grown around the silica core by an electroless plating method that 
requires an aged Au solution, therefore make this solution at least 48 hours before nanoshell 
synthesis is performed.   
6.2) Measure out 200 mL of deionized water and put it into an amber bottle.  Add 50 
mg of potassium carbonate and then add 3 mL of aged Au salt solution (1% HAuCl4).  Cap 
the container and shake rigorously for 30 s to mix the solution.  Store the solution in a dark 
cabinet at room temperature.  Use the solution after 48 hours and before 7 days old.  The 
final concentrations of potassium carbonate and Au(III) Chloride Hydrate are 1.8 mM and 435 
µM (0.01478% (m/v)), respectively.  
7) Au Shell Growth via Electroless Plating 
7.1) The growth of the Au shell proceeds by mixing different volumes of the seed 
particle solution to the Au salt/potassium carbonate electroless plating solution and then 
adding a fixed volume of reductant.  For this protocol, formaldehyde is used as the 
reductant (Sigma Aldrich, 36.5-38% in H2O); however, other reductants such as Carbon 
Monoxide and Sodium borohydride can be used.    
7.2) Sonicate the solution of seed particles for 1 – 2 minutes in the bath sonicator 
and get  10 plastic cuvettes (4 ml capacity) and number them 1-10.  Add 3 mL of the 
electroless plating solution to each plastic cuvette.   
7.3) Add 40 µL of the seed particle solution to cuvette number 1.  Increase the 
volume of seed solution added to each cuvette by 10µL increments up to the tenth cuvette, 
which should have 130 uL seed in it.  Add 15 uL formaldehyde solution (Sigma Aldrich, 
36.5-38% in H2O) to each cuvette.  Cap the cuvette, shake vigorously for 3 minutes, and allow 
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to stand for 2 minutes.  The solution will change from colorless to a color which is dependent 
upon the size of silica core and the thickness of the Au shell.   
7.4) Using a UV-VIS-NIR Spectrophotometer, take an extinction measurement of 
each cuvette to determine the plasmon resonance peak of each nanoshell sample. Adding 
more seed particles will result in thinner shells that redshift the plasmon resonance and 
adding less seed will result in thicker shells that blue shift the plasmon resonance (Figure B-
4). See troubleshooting in the discussion section if none of the cuvettes resulted in the desired 
plasmon resonance wavelength.  
7.5) Scale up your nanoshell batch by repeating the above procedure with a larger 
volume of plating solution, seed solution, and formaldehyde in the selected ratio that resulted 
in the desired plasmon resonance. Stir for 10 minutes. Centrifuge the nanoshells at the 
required speed (Table B-1) for 20 minutes.  Pipette off the supernatant from the nanoshell 
pellet and resuspend the pellet in deionized water by vortexing and bath sonication at 
medium power. Repeat centrifugation 1-2 more times.  
7.6) Always check to see if the Au shell is complete by either SEM or TEM.  A UV-
Vis-NIR spectrum might look good, but the shell can still have cracks in it, which is 
undesirable for most nanoshell applications. 
8) Representative Results 
An UV-Vis-NIR extinction spectrum and a scanning electron microscope (SEM) 
image of a [60, 74] nm nanoshell is shown in figure B-2 and B-3, respectively.  It is very 
important to look at the nanoshells with a SEM to make sure the synthesized nanoshells are 
free of cracks, holes, defects, or aggregates.  For a well-synthesized batch of nanoshells on 
120 nm diameter silica cores the extinction spectrum should look similar to figure B-2.  The 
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peak largest peak at ~800 nm is the dipole resonance and the shoulder at ~600 nm is the 
quadruple resonance.  Also, the peak: trough ratio should be a 3 or greater (peak: trough ≥ 3).  
For example, the spectrum in figure B-2, the peak intensity at ~800 nm is 2 and the trough 
~500nm is ~0.45 making the ratio ~4     
 
Figure B-2. Silica core/Au shell nanoshell, [r1, r2] = [60, 74] nm. The peak (2 at ~800nm) 
to trough (.45 at ~500nm) ratio should be a minimum of~ 3 for complete shells. 
 
 
Figure B-3. Scanning electron microscope image of a [r1, r2] = [60, 74] nm Au 
nanoshells.   
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Figure B-4 shows how the extinction spectra change as the volume of seed particles is 
varied.  Adding the least amount of seed results in the thickest shell and the quadrupole peak 
is larger (Figure B-4A).  As the volume of seed is increased, the Au shell thickness 
decreases, the quadruple becomes smaller, and the dipole peak redshifts to longer 
wavelengths (Figure B-4B-C).  If an excess of seed is added, the Au shell is incomplete, the 
quadrupole is not visible, and the dipole peak blueshifts (Figure B-4D).  Additionally, if the 
nanoshell extinction spectrum has a peak: trough ratio less than 3, then this is strong 
indication that the Au shell is incomplete.   
 
Figure B-4.  Extinction spectra of Au nanoshells fabricated on 120nm diameter silica 
particles.  Decreasing the volume of seed particle solution results in a thicker Au shell 
and a blueshift of the the plasmon resonance.  (A) Complete nanoshells with thick Au 
shell. (B-C) The Au shell becomes thinner as the volume of seed added is increased and 
the plasmon resonance redshifts.  The quadrupole (~600 nm) becomes smaller for 
thinner shells.  (D) Incomplete Au shell.  The quadruple (~600 nm) is not visible for 
incomplete shells. Figure adapted from Ref. 
245
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The peak: trough ratio and plasmon resonance extinction line shape (dipole 
quadrupole, and sometimes octopole peak intensities) will vary when changing the size of the 
silica core and the thickness of the Au shell.  For example nanoshells synthesized on a 80 nm 
diameter silica core with a 10 nm thick Au shell, do not have a quadrupole shoulder.  
Therefore, theoretical calculations (Mie theory, COMSOL Multiphysics, etc) should be 
performed to predict the line shape and peak: trough ratio of the nanoshell extinction 
spectrum.   
 
Name of the reagent Company Catalogue 
number 
Comments  
Au(III) Chloride Hydrate Sigma Aldrich 254169  99.999% 
Tetrakis(hydroxymethyl)phosphonium 
Chloride Solution  
Sigma Aldrich 404861 (80% in H2O) 
1M Sodium Hydroxide  Acros Organics 124260010  
 
Tetraethyl Orthosilicate Sigma Aldrich 333859 99.999% 
Ammonium Hydroxide Sigma Aldrich 338818 28% NH3 in H20, 
≥99.99% trace 
metals basis 
200 Proof Ethyl Alcohol Sigma Aldrich 459844  
(3-Aminopropyl)triethoxysilane 
 
Sigma Aldrich A3648  
Sodium Chloride Sigma Aldrich S7653  
Potassium carbonate 
 
Sigma Aldrich P5833  
Formaldehyde solution 
 
Sigma Aldrich F8775 36.5-38% in H2O 
Table B-2. Reagents needed for synthesis of silica-Au nanoshells. 
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